region,iso3c,country,year,vaccine,vaccine_code,vaccine_desc,target,doses,coverage
Industrialized,AND,Andorra,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,49
Industrialized,AND,Andorra,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,64
Industrialized,AND,Andorra,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,77
Industrialized,AND,Andorra,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,49
Industrialized,AND,Andorra,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,64
Industrialized,AND,Andorra,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,77
MENA,ARE,United Arab Emirates,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,36293,9837,27
MENA,ARE,United Arab Emirates,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,37528,10353,28
MENA,ARE,United Arab Emirates,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,42942,18729,44
MENA,ARE,United Arab Emirates,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,36293,9738,27
MENA,ARE,United Arab Emirates,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,37528,10241,27
MENA,ARE,United Arab Emirates,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,42942,12514,29
LACR,ARG,Argentina,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,344013,297385,86
LACR,ARG,Argentina,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,345592,230625,67
LACR,ARG,Argentina,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,347163,283681,82
LACR,ARG,Argentina,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,348659,281069,81
LACR,ARG,Argentina,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,349494,281467,81
LACR,ARG,Argentina,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,349951,292853,84
LACR,ARG,Argentina,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,350734,288263,82
LACR,ARG,Argentina,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,351531,311100,88
LACR,ARG,Argentina,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,352634,306816,87
LACR,ARG,Argentina,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,345592,128040,37
LACR,ARG,Argentina,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,347163,196648,57
LACR,ARG,Argentina,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,348659,189362,54
LACR,ARG,Argentina,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,349494,169678,49
LACR,ARG,Argentina,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,349951,195943,56
LACR,ARG,Argentina,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,350734,171164,49
LACR,ARG,Argentina,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,351531,203734,58
LACR,ARG,Argentina,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,352634,208229,59
LACR,ARG,Argentina,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,354655,158948,45
LACR,ARG,Argentina,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,343786,297385,87
LACR,ARG,Argentina,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,345426,230625,67
LACR,ARG,Argentina,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,347186,283681,82
LACR,ARG,Argentina,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,348646,288548,83
LACR,ARG,Argentina,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,349406,296391,85
LACR,ARG,Argentina,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,349746,327200,94
LACR,ARG,Argentina,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,345426,128040,37
LACR,ARG,Argentina,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,347186,196648,57
LACR,ARG,Argentina,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,348646,201986,58
LACR,ARG,Argentina,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,349406,196985,56
LACR,ARG,Argentina,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,349746,240619,69
CEECIS,ARM,Armenia,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,16736,1070,6
CEECIS,ARM,Armenia,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,17340,3006,17
CEECIS,ARM,Armenia,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,18046,1783,10
CEECIS,ARM,Armenia,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,16736,339,2
CEECIS,ARM,Armenia,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,17340,1233,7
CEECIS,ARM,Armenia,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,18046,1522,8
CEECIS,ARM,Armenia,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,16673,1224,7
CEECIS,ARM,Armenia,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,16673,339,2
LACR,ATG,Antigua and Barbuda,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,3373,345,10
LACR,ATG,Antigua and Barbuda,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,10
Industrialized,AUS,Australia,2010,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,134922,105657,78
Industrialized,AUS,Australia,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,135507,103235,76
Industrialized,AUS,Australia,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,135910,104102,77
Industrialized,AUS,Australia,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,136270,96873,71
Industrialized,AUS,Australia,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,74
Industrialized,AUS,Australia,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,136891,104082,76
Industrialized,AUS,Australia,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,79
Industrialized,AUS,Australia,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,145441,119154,82
Industrialized,AUS,Australia,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,85
Industrialized,AUS,Australia,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,154264,136636,89
Industrialized,AUS,Australia,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,158080,116791,74
Industrialized,AUS,Australia,2010,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,134922,90104,67
Industrialized,AUS,Australia,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,135507,85406,63
Industrialized,AUS,Australia,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,135910,88194,65
Industrialized,AUS,Australia,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,136270,89120,65
Industrialized,AUS,Australia,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,66
Industrialized,AUS,Australia,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,136891,92030,67
Industrialized,AUS,Australia,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,71
Industrialized,AUS,Australia,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,72
Industrialized,AUS,Australia,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,149800,110671,74
Industrialized,AUS,Australia,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,154264,122201,79
Industrialized,AUS,Australia,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,158080,104756,66
Industrialized,AUS,Australia,2012,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,84
Industrialized,AUS,Australia,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,83
Industrialized,AUS,Australia,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,85
Industrialized,AUS,Australia,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,88
Industrialized,AUS,Australia,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,88
Industrialized,AUS,Australia,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,89
Industrialized,AUS,Australia,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,89
Industrialized,AUS,Australia,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,89
Industrialized,AUS,Australia,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,89
Industrialized,AUS,Australia,2012,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,72
Industrialized,AUS,Australia,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,72
Industrialized,AUS,Australia,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,75
Industrialized,AUS,Australia,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,79
Industrialized,AUS,Australia,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,80
Industrialized,AUS,Australia,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,80
Industrialized,AUS,Australia,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,77
Industrialized,AUS,Australia,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,75
Industrialized,AUS,Australia,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,72
Industrialized,BEL,Belgium,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,63
Industrialized,BEL,Belgium,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,65
Industrialized,BEL,Belgium,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,67
Industrialized,BEL,Belgium,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,69
Industrialized,BEL,Belgium,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,71
Industrialized,BEL,Belgium,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,71
Industrialized,BEL,Belgium,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,71
Industrialized,BEL,Belgium,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,71
Industrialized,BEL,Belgium,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,61
Industrialized,BEL,Belgium,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,63
Industrialized,BEL,Belgium,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,64
Industrialized,BEL,Belgium,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,66
Industrialized,BEL,Belgium,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,67
Industrialized,BEL,Belgium,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,67
Industrialized,BEL,Belgium,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,67
Industrialized,BEL,Belgium,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,67
Industrialized,BEL,Belgium,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,63
Industrialized,BEL,Belgium,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,65
Industrialized,BEL,Belgium,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,67
Industrialized,BEL,Belgium,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,69
Industrialized,BEL,Belgium,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,71
Industrialized,BEL,Belgium,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,71
Industrialized,BEL,Belgium,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,71
Industrialized,BEL,Belgium,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,61
Industrialized,BEL,Belgium,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,63
Industrialized,BEL,Belgium,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,64
Industrialized,BEL,Belgium,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,66
Industrialized,BEL,Belgium,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,67
Industrialized,BEL,Belgium,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,67
Industrialized,BEL,Belgium,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,67
CEECIS,BGR,Bulgaria,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,29320,7470,25
CEECIS,BGR,Bulgaria,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,29782,4633,16
CEECIS,BGR,Bulgaria,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,55595,3759,7
CEECIS,BGR,Bulgaria,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,59204,2651,4
CEECIS,BGR,Bulgaria,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,62755,3115,5
CEECIS,BGR,Bulgaria,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,65329,4610,7
CEECIS,BGR,Bulgaria,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,67519,4272,6
CEECIS,BGR,Bulgaria,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,70459,2431,3
CEECIS,BGR,Bulgaria,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,29320,6535,22
CEECIS,BGR,Bulgaria,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,29782,4214,14
CEECIS,BGR,Bulgaria,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,56014,2490,4
CEECIS,BGR,Bulgaria,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,60037,1917,3
CEECIS,BGR,Bulgaria,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,63263,2160,3
CEECIS,BGR,Bulgaria,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,65885,3385,5
CEECIS,BGR,Bulgaria,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,68279,2709,4
CEECIS,BGR,Bulgaria,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,71061,1642,2
CEECIS,BGR,Bulgaria,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,29167,7470,26
CEECIS,BGR,Bulgaria,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,29555,5372,18
CEECIS,BGR,Bulgaria,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,30310,3609,12
CEECIS,BGR,Bulgaria,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,31507,2914,9
CEECIS,BGR,Bulgaria,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,32957,3798,12
CEECIS,BGR,Bulgaria,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,29167,6535,22
CEECIS,BGR,Bulgaria,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,29555,4517,15
CEECIS,BGR,Bulgaria,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,30310,2550,8
CEECIS,BGR,Bulgaria,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,31507,2007,6
CEECIS,BGR,Bulgaria,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,32957,2777,8
LACR,BHS,Bahamas,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,6395,386,6
LACR,BHS,Bahamas,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,6404,2683,42
LACR,BHS,Bahamas,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,6393,1875,29
LACR,BHS,Bahamas,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,6334,1336,21
LACR,BHS,Bahamas,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,6166,1770,29
LACR,BHS,Bahamas,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,6395,139,2
LACR,BHS,Bahamas,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,6404,1188,19
LACR,BHS,Bahamas,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,6393,1088,17
LACR,BHS,Bahamas,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,6334,628,10
LACR,BHS,Bahamas,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,6166,532,9
LACR,BHS,Bahamas,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,6441,421,7
LACR,BHS,Bahamas,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,6441,821,13
LACR,BHS,Bahamas,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,6441,340,5
LACR,BHS,Bahamas,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,6441,466,7
LACR,BLZ,Belize,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,3791,2092,55
LACR,BLZ,Belize,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,3740,2103,56
LACR,BLZ,Belize,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,3698,2201,60
LACR,BLZ,Belize,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,3693,2848,77
LACR,BLZ,Belize,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,3730,1903,51
LACR,BLZ,Belize,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,3740,1911,51
LACR,BLZ,Belize,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,3698,1995,54
LACR,BLZ,Belize,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,3693,2323,63
LACR,BLZ,Belize,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,3730,415,11
LACR,BOL,Bolivia (Plurinational State of),2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,341277,257105,75
LACR,BOL,Bolivia (Plurinational State of),2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,114001,81726,72
LACR,BOL,Bolivia (Plurinational State of),2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,114146,91511,80
LACR,BOL,Bolivia (Plurinational State of),2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,114424,68422,60
LACR,BOL,Bolivia (Plurinational State of),2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,341277,226299,66
LACR,BOL,Bolivia (Plurinational State of),2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,114001,70804,62
LACR,BOL,Bolivia (Plurinational State of),2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,114146,79646,70
LACR,BOL,Bolivia (Plurinational State of),2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,114424,27860,24
LACR,BOL,Bolivia (Plurinational State of),2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,112780,87473,78
LACR,BOL,Bolivia (Plurinational State of),2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,112780,78889,70
LACR,BRA,Brazil,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,4866149,4958969,99
LACR,BRA,Brazil,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,4617931,3476086,75
LACR,BRA,Brazil,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1483142,1239305,84
LACR,BRA,Brazil,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1458636,1710607,99
LACR,BRA,Brazil,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1590611,1211537,76
LACR,BRA,Brazil,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1590611,1192333,75
LACR,BRA,Brazil,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1590611,1391968,88
LACR,BRA,Brazil,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,4866149,2875461,59
LACR,BRA,Brazil,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,4617931,2287620,50
LACR,BRA,Brazil,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1483142,1068124,72
LACR,BRA,Brazil,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1458636,1411812,97
LACR,BRA,Brazil,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1590611,1139329,72
LACR,BRA,Brazil,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1590611,990964,62
LACR,BRA,Brazil,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1590611,1149472,72
LACR,BRA,Brazil,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,1645196,1582368,96
LACR,BRA,Brazil,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,1622162,1634185,99
LACR,BRA,Brazil,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,1738274,1990060,99
LACR,BRA,Brazil,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,1738274,1131228,65
LACR,BRA,Brazil,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,1738274,1552995,89
LACR,BRA,Brazil,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,1645196,1091200,66
LACR,BRA,Brazil,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,1622162,1213121,75
LACR,BRA,Brazil,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,1738274,1099724,63
LACR,BRA,Brazil,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,1738274,1147668,66
LACR,BRA,Brazil,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,1738274,1153237,66
LACR,BRB,Barbados,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1862,394,21
LACR,BRB,Barbados,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1845,1364,74
LACR,BRB,Barbados,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1819,1531,84
LACR,BRB,Barbados,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1792,655,37
LACR,BRB,Barbados,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1766,1138,64
LACR,BRB,Barbados,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1734,1137,66
LACR,BRB,Barbados,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1691,1080,64
LACR,BRB,Barbados,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1862,143,8
LACR,BRB,Barbados,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1845,554,30
LACR,BRB,Barbados,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1819,275,15
LACR,BRB,Barbados,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1792,259,14
LACR,BRB,Barbados,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1766,451,26
LACR,BRB,Barbados,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1734,507,29
LACR,BRB,Barbados,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1691,124,7
LACR,BRB,Barbados,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,1858,391,21
LACR,BRB,Barbados,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,1840,1366,74
LACR,BRB,Barbados,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,1814,1540,85
LACR,BRB,Barbados,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,1858,143,8
LACR,BRB,Barbados,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,1840,554,30
LACR,BRB,Barbados,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,1814,286,16
EAPR,BRN,Brunei Darussalam,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,6786,6859,99
EAPR,BRN,Brunei Darussalam,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,6750,6017,89
EAPR,BRN,Brunei Darussalam,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,6715,5666,84
EAPR,BRN,Brunei Darussalam,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,6696,5402,81
EAPR,BRN,Brunei Darussalam,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,3311,2934,89
EAPR,BRN,Brunei Darussalam,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,3246,2901,89
EAPR,BRN,Brunei Darussalam,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,3164,2898,92
EAPR,BRN,Brunei Darussalam,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,3086,2823,91
EAPR,BRN,Brunei Darussalam,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,2985,2622,88
EAPR,BRN,Brunei Darussalam,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,6786,6651,98
EAPR,BRN,Brunei Darussalam,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,6750,5717,85
EAPR,BRN,Brunei Darussalam,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,6715,5426,81
EAPR,BRN,Brunei Darussalam,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,6696,5179,77
EAPR,BRN,Brunei Darussalam,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,3311,2866,87
EAPR,BRN,Brunei Darussalam,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,3246,2861,88
EAPR,BRN,Brunei Darussalam,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,3164,2828,89
EAPR,BRN,Brunei Darussalam,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,3086,2781,90
EAPR,BRN,Brunei Darussalam,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,2985,2562,86
EAPR,BRN,Brunei Darussalam,2012,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,99
EAPR,BRN,Brunei Darussalam,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,89
EAPR,BRN,Brunei Darussalam,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,84
EAPR,BRN,Brunei Darussalam,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,81
EAPR,BRN,Brunei Darussalam,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,81
EAPR,BRN,Brunei Darussalam,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,81
EAPR,BRN,Brunei Darussalam,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,3314,2934,89
EAPR,BRN,Brunei Darussalam,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,89
EAPR,BRN,Brunei Darussalam,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,3164,2898,92
EAPR,BRN,Brunei Darussalam,2012,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,98
EAPR,BRN,Brunei Darussalam,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,85
EAPR,BRN,Brunei Darussalam,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,81
EAPR,BRN,Brunei Darussalam,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,77
EAPR,BRN,Brunei Darussalam,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,87
EAPR,BRN,Brunei Darussalam,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,87
EAPR,BRN,Brunei Darussalam,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,3314,2866,86
EAPR,BRN,Brunei Darussalam,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,3252,2861,88
EAPR,BRN,Brunei Darussalam,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,3164,2828,89
ROSA,BTN,Bhutan,2010,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,7497,6301,84
ROSA,BTN,Bhutan,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,7374,5590,76
ROSA,BTN,Bhutan,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,84
ROSA,BTN,Bhutan,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,84
ROSA,BTN,Bhutan,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,98
ROSA,BTN,Bhutan,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,99
ROSA,BTN,Bhutan,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,6850,6800,99
ROSA,BTN,Bhutan,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,6771,6642,98
ROSA,BTN,Bhutan,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,6692,6432,96
ROSA,BTN,Bhutan,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,6626,5873,89
ROSA,BTN,Bhutan,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,6554,5490,84
ROSA,BTN,Bhutan,2010,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,7497,6579,88
ROSA,BTN,Bhutan,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,7374,5076,69
ROSA,BTN,Bhutan,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,7262,5297,73
ROSA,BTN,Bhutan,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,68
ROSA,BTN,Bhutan,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,94
ROSA,BTN,Bhutan,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,96
ROSA,BTN,Bhutan,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,6850,6738,98
ROSA,BTN,Bhutan,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,6692,6393,96
ROSA,BTN,Bhutan,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,6626,4863,73
ROSA,BTN,Bhutan,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,6554,5287,81
ROSA,BTN,Bhutan,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,7425,6301,85
ROSA,BTN,Bhutan,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,7332,5590,76
ROSA,BTN,Bhutan,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,84
ROSA,BTN,Bhutan,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,84
ROSA,BTN,Bhutan,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,98
ROSA,BTN,Bhutan,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,99
ROSA,BTN,Bhutan,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,6805,6800,100
ROSA,BTN,Bhutan,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,6734,6642,99
ROSA,BTN,Bhutan,2011,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,90
ROSA,BTN,Bhutan,2012,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,90
ROSA,BTN,Bhutan,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,7425,6579,89
ROSA,BTN,Bhutan,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,7332,5076,69
ROSA,BTN,Bhutan,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,7229,5297,73
ROSA,BTN,Bhutan,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,68
ROSA,BTN,Bhutan,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,94
ROSA,BTN,Bhutan,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,96
ROSA,BTN,Bhutan,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,6805,6738,99
ESAR,BWA,Botswana,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,90050,71054,79
ESAR,BWA,Botswana,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,23495,22809,97
ESAR,BWA,Botswana,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,23896,22002,92
ESAR,BWA,Botswana,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,24803,21592,87
ESAR,BWA,Botswana,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,48353,26727,55
ESAR,BWA,Botswana,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,90050,60330,67
ESAR,BWA,Botswana,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,23495,18441,78
ESAR,BWA,Botswana,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,24803,11559,47
ESAR,BWA,Botswana,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,21241,8013,38
ESAR,BWA,Botswana,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,21784,18940,87
ESAR,BWA,Botswana,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,22312,21698,97
ESAR,BWA,Botswana,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,22759,19831,87
ESAR,BWA,Botswana,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,23142,19287,83
ESAR,BWA,Botswana,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,21241,3919,18
ESAR,BWA,Botswana,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,21784,10387,48
ESAR,BWA,Botswana,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,22312,17536,79
ESAR,BWA,Botswana,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,22759,19420,85
ESAR,BWA,Botswana,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,23142,20077,87
Industrialized,CAN,Canada,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,73
Industrialized,CAN,Canada,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,74
Industrialized,CAN,Canada,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,75
Industrialized,CAN,Canada,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,79
Industrialized,CAN,Canada,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,83
Industrialized,CAN,Canada,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,83
Industrialized,CAN,Canada,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,83
Industrialized,CAN,Canada,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,87
Industrialized,CAN,Canada,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,73
Industrialized,CAN,Canada,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,74
Industrialized,CAN,Canada,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,75
Industrialized,CAN,Canada,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,79
Industrialized,CAN,Canada,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,83
Industrialized,CAN,Canada,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,83
Industrialized,CAN,Canada,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,83
Industrialized,CAN,Canada,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,87
Industrialized,CAN,Canada,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,73
Industrialized,CAN,Canada,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,74
Industrialized,CAN,Canada,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,75
Industrialized,CAN,Canada,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,79
Industrialized,CAN,Canada,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,83
Industrialized,CAN,Canada,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,83
Industrialized,CAN,Canada,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,83
Industrialized,CAN,Canada,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,87
Industrialized,CAN,Canada,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,73
Industrialized,CAN,Canada,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,74
Industrialized,CAN,Canada,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,75
Industrialized,CAN,Canada,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,79
Industrialized,CAN,Canada,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,83
Industrialized,CAN,Canada,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,83
Industrialized,CAN,Canada,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,83
Industrialized,CAN,Canada,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,87
Industrialized,CHE,Switzerland,2010,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,26
Industrialized,CHE,Switzerland,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,56
Industrialized,CHE,Switzerland,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,56
Industrialized,CHE,Switzerland,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,56
Industrialized,CHE,Switzerland,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,59
Industrialized,CHE,Switzerland,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,59
Industrialized,CHE,Switzerland,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,59
Industrialized,CHE,Switzerland,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,64
Industrialized,CHE,Switzerland,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,64
Industrialized,CHE,Switzerland,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,64
Industrialized,CHE,Switzerland,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,67
Industrialized,CHE,Switzerland,2010,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,20
Industrialized,CHE,Switzerland,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,51
Industrialized,CHE,Switzerland,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,51
Industrialized,CHE,Switzerland,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,51
Industrialized,CHE,Switzerland,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,56
Industrialized,CHE,Switzerland,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,56
Industrialized,CHE,Switzerland,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,56
Industrialized,CHE,Switzerland,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,59
Industrialized,CHE,Switzerland,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,59
Industrialized,CHE,Switzerland,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,59
Industrialized,CHE,Switzerland,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,63
Industrialized,CHE,Switzerland,2010,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,26
Industrialized,CHE,Switzerland,2011,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,56
Industrialized,CHE,Switzerland,2012,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,56
Industrialized,CHE,Switzerland,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,56
Industrialized,CHE,Switzerland,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,59
Industrialized,CHE,Switzerland,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,59
Industrialized,CHE,Switzerland,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,59
Industrialized,CHE,Switzerland,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,64
Industrialized,CHE,Switzerland,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,64
Industrialized,CHE,Switzerland,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,64
Industrialized,CHE,Switzerland,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,67
Industrialized,CHE,Switzerland,2010,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,20
Industrialized,CHE,Switzerland,2011,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,51
Industrialized,CHE,Switzerland,2012,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,51
Industrialized,CHE,Switzerland,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,51
Industrialized,CHE,Switzerland,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,56
Industrialized,CHE,Switzerland,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,56
Industrialized,CHE,Switzerland,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,56
Industrialized,CHE,Switzerland,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,59
Industrialized,CHE,Switzerland,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,59
Industrialized,CHE,Switzerland,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,59
Industrialized,CHE,Switzerland,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,63
LACR,CHL,Chile,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,118601,96868,82
LACR,CHL,Chile,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,119758,94867,79
LACR,CHL,Chile,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,120708,90056,75
LACR,CHL,Chile,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,121980,97498,80
LACR,CHL,Chile,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,123272,107866,88
LACR,CHL,Chile,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,124241,114286,92
LACR,CHL,Chile,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,124712,96836,78
LACR,CHL,Chile,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,119225,86785,73
LACR,CHL,Chile,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,120126,89999,75
LACR,CHL,Chile,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,121273,82853,68
LACR,CHL,Chile,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,122563,91899,75
LACR,CHL,Chile,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,123623,100929,82
LACR,CHL,Chile,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,124210,91991,74
LACR,CHL,Chile,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,120798,96868,80
LACR,CHL,Chile,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,120798,86785,72
WCAR,CIV,Cote d'Ivoire,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,333786,21515,6
WCAR,CIV,Cote d'Ivoire,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,341859,229706,67
WCAR,CIV,Cote d'Ivoire,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,333299,44185,13
WCAR,CMR,Cameroon,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,354205,16440,5
EAPR,COK,Cook Islands,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,481,362,75
EAPR,COK,Cook Islands,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,242,269,99
EAPR,COK,Cook Islands,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,98,118,99
EAPR,COK,Cook Islands,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,132,126,95
EAPR,COK,Cook Islands,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,108,86,80
EAPR,COK,Cook Islands,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,108,41,38
EAPR,COK,Cook Islands,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,144,139,97
EAPR,COK,Cook Islands,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,97
EAPR,COK,Cook Islands,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,481,356,74
EAPR,COK,Cook Islands,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,242,116,48
EAPR,COK,Cook Islands,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,98,126,99
EAPR,COK,Cook Islands,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,132,110,83
EAPR,COK,Cook Islands,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,108,44,41
EAPR,COK,Cook Islands,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,108,75,69
EAPR,COK,Cook Islands,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,144,101,70
EAPR,COK,Cook Islands,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,112,82,73
EAPR,COK,Cook Islands,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,89,95,99
EAPR,COK,Cook Islands,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,84,62,74
EAPR,COK,Cook Islands,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,78,64,82
EAPR,COK,Cook Islands,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,73,63,86
EAPR,COK,Cook Islands,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,67,168,99
EAPR,COK,Cook Islands,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,65,90,99
EAPR,COK,Cook Islands,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,60,116,99
EAPR,COK,Cook Islands,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,89,95,99
EAPR,COK,Cook Islands,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,84,62,74
EAPR,COK,Cook Islands,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,78,63,81
EAPR,COK,Cook Islands,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,73,63,86
EAPR,COK,Cook Islands,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,67,73,99
EAPR,COK,Cook Islands,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,65,116,99
EAPR,COK,Cook Islands,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,60,26,43
LACR,COL,Colombia,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,410274,362076,88
LACR,COL,Colombia,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,2307744,1572662,68
LACR,COL,Colombia,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,842349,245084,29
LACR,COL,Colombia,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,387035,182656,47
LACR,COL,Colombia,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,380285,42520,11
LACR,COL,Colombia,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,374485,124707,33
LACR,COL,Colombia,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,370453,238407,64
LACR,COL,Colombia,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,370564,262720,71
LACR,COL,Colombia,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,385180,219806,57
LACR,COL,Colombia,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,410274,350058,85
LACR,COL,Colombia,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,2324222,1183829,51
LACR,COL,Colombia,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1178310,336320,29
LACR,COL,Colombia,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,387035,93026,24
LACR,COL,Colombia,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,380285,29506,8
LACR,COL,Colombia,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,374485,54500,15
LACR,COL,Colombia,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,370453,110720,30
LACR,COL,Colombia,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,370564,142085,38
LACR,COL,Colombia,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,385180,132290,34
LACR,COL,Colombia,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,416720,320303,77
LACR,COL,Colombia,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,416476,354884,85
LACR,COL,Colombia,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,417316,366947,88
LACR,COL,Colombia,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,417875,384743,92
LACR,COL,Colombia,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,415798,351722,85
LACR,COL,Colombia,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,409986,312097,76
LACR,COL,Colombia,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,401580,227020,57
LACR,COL,Colombia,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,416720,255232,61
LACR,COL,Colombia,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,416476,328571,79
LACR,COL,Colombia,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,417316,336060,81
LACR,COL,Colombia,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,417875,351035,84
LACR,COL,Colombia,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,415798,342097,82
LACR,COL,Colombia,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,409986,235141,57
LACR,COL,Colombia,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,401580,133510,33
LACR,CRI,Costa Rica,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,36339,35722,98
LACR,CRI,Costa Rica,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,39
LACR,CRI,Costa Rica,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,34796,26754,77
Industrialized,CYP,Cyprus,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,8640,4932,57
Industrialized,CYP,Cyprus,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,4380,2552,58
Industrialized,CYP,Cyprus,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,4380,2575,59
Industrialized,CYP,Cyprus,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,4506,3270,73
Industrialized,CYP,Cyprus,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,8640,4943,57
Industrialized,CYP,Cyprus,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,4380,2796,64
Industrialized,CYP,Cyprus,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,64
Industrialized,CYP,Cyprus,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,4380,2256,52
Industrialized,CYP,Cyprus,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,4380,2447,56
Industrialized,CYP,Cyprus,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,4380,2346,54
Industrialized,CYP,Cyprus,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,4380,2597,59
Industrialized,DEU,Germany,2010,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,40
Industrialized,DEU,Germany,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,40
Industrialized,DEU,Germany,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,41
Industrialized,DEU,Germany,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,43
Industrialized,DEU,Germany,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,45
Industrialized,DEU,Germany,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,48
Industrialized,DEU,Germany,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,52
Industrialized,DEU,Germany,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,55
Industrialized,DEU,Germany,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,58
Industrialized,DEU,Germany,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,58
Industrialized,DEU,Germany,2010,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,27
Industrialized,DEU,Germany,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,27
Industrialized,DEU,Germany,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,27
Industrialized,DEU,Germany,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,29
Industrialized,DEU,Germany,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,31
Industrialized,DEU,Germany,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,33
Industrialized,DEU,Germany,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,37
Industrialized,DEU,Germany,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,40
Industrialized,DEU,Germany,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,43
Industrialized,DEU,Germany,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,43
Industrialized,DEU,Germany,2010,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,40
Industrialized,DEU,Germany,2011,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,40
Industrialized,DEU,Germany,2012,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,41
Industrialized,DEU,Germany,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,43
Industrialized,DEU,Germany,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,45
Industrialized,DEU,Germany,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,48
Industrialized,DEU,Germany,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,52
Industrialized,DEU,Germany,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,55
Industrialized,DEU,Germany,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,58
Industrialized,DEU,Germany,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,58
Industrialized,DEU,Germany,2010,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,27
Industrialized,DEU,Germany,2011,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,27
Industrialized,DEU,Germany,2012,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,27
Industrialized,DEU,Germany,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,29
Industrialized,DEU,Germany,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,31
Industrialized,DEU,Germany,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,33
Industrialized,DEU,Germany,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,37
Industrialized,DEU,Germany,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,40
Industrialized,DEU,Germany,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,43
Industrialized,DEU,Germany,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,43
LACR,DMA,Dominica,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,502,405,81
LACR,DMA,Dominica,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,505,325,64
LACR,DMA,Dominica,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,505,325,64
Industrialized,DNK,Denmark,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,33884,22000,65
Industrialized,DNK,Denmark,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,34127,22654,66
Industrialized,DNK,Denmark,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,34507,29771,86
Industrialized,DNK,Denmark,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,33665,26298,78
Industrialized,DNK,Denmark,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,32887,23347,71
Industrialized,DNK,Denmark,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,33242,15768,47
Industrialized,DNK,Denmark,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,33360,19352,58
Industrialized,DNK,Denmark,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,33293,24491,74
Industrialized,DNK,Denmark,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,33409,26234,79
Industrialized,DNK,Denmark,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,33085,27793,84
Industrialized,DNK,Denmark,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,33884,23000,68
Industrialized,DNK,Denmark,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,34127,24415,72
Industrialized,DNK,Denmark,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,34507,25815,75
Industrialized,DNK,Denmark,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,33665,22076,66
Industrialized,DNK,Denmark,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,32887,18220,55
Industrialized,DNK,Denmark,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,33242,5173,16
Industrialized,DNK,Denmark,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,33360,11926,36
Industrialized,DNK,Denmark,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,33293,17881,54
Industrialized,DNK,Denmark,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,33409,20667,62
Industrialized,DNK,Denmark,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,33085,23156,70
Industrialized,DNK,Denmark,2010,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,83
Industrialized,DNK,Denmark,2011,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,85
Industrialized,DNK,Denmark,2012,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,87
Industrialized,DNK,Denmark,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,90
Industrialized,DNK,Denmark,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,92
Industrialized,DNK,Denmark,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,92
Industrialized,DNK,Denmark,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,92
Industrialized,DNK,Denmark,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,89
Industrialized,DNK,Denmark,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,88
Industrialized,DNK,Denmark,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,85
Industrialized,DNK,Denmark,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,33360,28655,86
Industrialized,DNK,Denmark,2010,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,70
Industrialized,DNK,Denmark,2011,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,73
Industrialized,DNK,Denmark,2012,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,73
Industrialized,DNK,Denmark,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,77
Industrialized,DNK,Denmark,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,79
Industrialized,DNK,Denmark,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,80
Industrialized,DNK,Denmark,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,80
Industrialized,DNK,Denmark,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,76
Industrialized,DNK,Denmark,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,73
Industrialized,DNK,Denmark,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,75
Industrialized,DNK,Denmark,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,33360,26246,79
LACR,DOM,Dominican Republic,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,191828,113417,59
LACR,DOM,Dominican Republic,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,96288,55805,58
LACR,DOM,Dominican Republic,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,96652,11703,12
LACR,DOM,Dominican Republic,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,97023,17248,18
LACR,DOM,Dominican Republic,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,191828,65669,34
LACR,DOM,Dominican Republic,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,96288,29587,31
LACR,DOM,Dominican Republic,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,96652,6283,7
LACR,DOM,Dominican Republic,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,97023,7000,7
LACR,ECU,Ecuador,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,491567,455363,93
LACR,ECU,Ecuador,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,167334,184795,99
LACR,ECU,Ecuador,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,164225,166038,99
LACR,ECU,Ecuador,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,165006,147874,90
LACR,ECU,Ecuador,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,165315,161359,98
LACR,ECU,Ecuador,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,165234,136034,82
LACR,ECU,Ecuador,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,154934,116038,75
LACR,ECU,Ecuador,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,491567,396606,81
LACR,ECU,Ecuador,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,167334,178358,99
LACR,ECU,Ecuador,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,164225,156603,95
LACR,ECU,Ecuador,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,165006,141593,86
LACR,ECU,Ecuador,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,165315,119567,72
LACR,ECU,Ecuador,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,165234,88616,54
LACR,ECU,Ecuador,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,154934,56365,36
LACR,ECU,Ecuador,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,165229,140571,85
LACR,ECU,Ecuador,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,163850,149361,91
LACR,ECU,Ecuador,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,165484,165431,100
LACR,ECU,Ecuador,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,165229,133046,81
LACR,ECU,Ecuador,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,163850,133877,82
LACR,ECU,Ecuador,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,165484,129683,78
Industrialized,ESP,Spain,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,85
Industrialized,ESP,Spain,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,81
Industrialized,ESP,Spain,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,84
Industrialized,ESP,Spain,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,84
Industrialized,ESP,Spain,2010,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,216021,127420,59
Industrialized,ESP,Spain,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,216948,137582,64
Industrialized,ESP,Spain,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,216176,149907,70
Industrialized,ESP,Spain,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,74
Industrialized,ESP,Spain,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,74
Industrialized,ESP,Spain,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,82
Industrialized,ESP,Spain,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,78
Industrialized,ESP,Spain,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,82
Industrialized,ESP,Spain,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,76
Industrialized,ESP,Spain,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,79
Industrialized,ESP,Spain,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,79
Industrialized,ESP,Spain,2010,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,55
Industrialized,ESP,Spain,2011,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,217008,125100,58
Industrialized,ESP,Spain,2012,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,57
Industrialized,ESP,Spain,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,58
Industrialized,ESP,Spain,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,65
Industrialized,ESP,Spain,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,214241,145985,68
Industrialized,ESP,Spain,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,69
Industrialized,ESP,Spain,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,211650,148023,70
Industrialized,ESP,Spain,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,89
Industrialized,ESP,Spain,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,85
Industrialized,ESP,Spain,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,227406,204776,90
Industrialized,ESP,Spain,2012,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,217812,127420,58
Industrialized,ESP,Spain,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,217584,137582,63
Industrialized,ESP,Spain,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,216075,149907,69
Industrialized,ESP,Spain,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,214241,158679,74
Industrialized,ESP,Spain,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,213292,156664,73
Industrialized,ESP,Spain,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,211650,173873,82
Industrialized,ESP,Spain,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,212958,185510,87
Industrialized,ESP,Spain,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,218899,175344,80
Industrialized,ESP,Spain,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,227406,181391,80
Industrialized,EST,Estonia,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,20013,10226,51
Industrialized,EST,Estonia,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,7234,3991,55
Industrialized,EST,Estonia,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,7429,4531,61
Industrialized,EST,Estonia,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,20013,9021,45
Industrialized,EST,Estonia,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,7234,3933,54
Industrialized,EST,Estonia,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,7429,4088,55
Industrialized,EST,Estonia,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,6336,3772,60
Industrialized,EST,Estonia,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,6569,3865,59
Industrialized,EST,Estonia,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,6336,3047,48
Industrialized,EST,Estonia,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,6569,3859,59
ESAR,ETH,Ethiopia,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1309271,1164615,89
ESAR,ETH,Ethiopia,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1322189,1239881,94
ESAR,ETH,Ethiopia,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1334518,1267437,95
ESAR,ETH,Ethiopia,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1322189,1111395,84
ESAR,ETH,Ethiopia,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1334518,1013957,76
ESAR,ETH,Ethiopia,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,1307764,1164615,89
ESAR,ETH,Ethiopia,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,1320461,1239881,94
ESAR,ETH,Ethiopia,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,1307764,1111395,85
ESAR,ETH,Ethiopia,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,1320461,1111395,84
Industrialized,FIN,Finland,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,62
Industrialized,FIN,Finland,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,60
Industrialized,FIN,Finland,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,62
Industrialized,FIN,Finland,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,60
EAPR,FJI,Fiji,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,7309,7168,98
EAPR,FJI,Fiji,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,7259,6691,92
EAPR,FJI,Fiji,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,7210,6528,91
EAPR,FJI,Fiji,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,7299,6791,93
EAPR,FJI,Fiji,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,7476,6738,90
EAPR,FJI,Fiji,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,7685,6619,86
EAPR,FJI,Fiji,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,7853,7333,93
EAPR,FJI,Fiji,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,7309,4301,59
EAPR,FJI,Fiji,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,7259,6484,89
EAPR,FJI,Fiji,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,7210,4865,67
EAPR,FJI,Fiji,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,7299,3845,53
EAPR,FJI,Fiji,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,7476,4164,56
EAPR,FJI,Fiji,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,7685,3711,48
EAPR,FJI,Fiji,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,7853,4398,56
EAPR,FJI,Fiji,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,7111,7168,99
EAPR,FJI,Fiji,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,7143,6691,94
EAPR,FJI,Fiji,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,7167,6528,91
EAPR,FJI,Fiji,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,7257,6791,94
EAPR,FJI,Fiji,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,7419,6738,91
EAPR,FJI,Fiji,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,7111,4301,60
EAPR,FJI,Fiji,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,7143,6484,91
EAPR,FJI,Fiji,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,7167,4865,68
EAPR,FJI,Fiji,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,7257,3845,53
EAPR,FJI,Fiji,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,7419,4164,56
Industrialized,FRA,France,2010,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,29
Industrialized,FRA,France,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,29
Industrialized,FRA,France,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,21
Industrialized,FRA,France,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,20
Industrialized,FRA,France,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,19
Industrialized,FRA,France,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,21
Industrialized,FRA,France,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,24
Industrialized,FRA,France,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,26
Industrialized,FRA,France,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,29
Industrialized,FRA,France,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,35
Industrialized,FRA,France,2010,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,25
Industrialized,FRA,France,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,22
Industrialized,FRA,France,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,17
Industrialized,FRA,France,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,16
Industrialized,FRA,France,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,13
Industrialized,FRA,France,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,20
Industrialized,FRA,France,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,21
Industrialized,FRA,France,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,24
Industrialized,FRA,France,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,24
Industrialized,FRA,France,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,33
Industrialized,FRA,France,2010,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,29
Industrialized,FRA,France,2011,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,29
Industrialized,FRA,France,2012,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,21
Industrialized,FRA,France,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,20
Industrialized,FRA,France,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,19
Industrialized,FRA,France,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,21
Industrialized,FRA,France,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,24
Industrialized,FRA,France,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,26
Industrialized,FRA,France,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,29
Industrialized,FRA,France,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,35
Industrialized,FRA,France,2010,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,25
Industrialized,FRA,France,2011,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,22
Industrialized,FRA,France,2012,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,17
Industrialized,FRA,France,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,16
Industrialized,FRA,France,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,13
Industrialized,FRA,France,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,20
Industrialized,FRA,France,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,21
Industrialized,FRA,France,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,24
Industrialized,FRA,France,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,24
Industrialized,FRA,France,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,33
EAPR,FSM,Micronesia (Federated States of),2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1161,830,71
EAPR,FSM,Micronesia (Federated States of),2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1169,895,77
EAPR,FSM,Micronesia (Federated States of),2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1175,820,70
EAPR,FSM,Micronesia (Federated States of),2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,70
EAPR,FSM,Micronesia (Federated States of),2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,2328,2378,99
EAPR,FSM,Micronesia (Federated States of),2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1158,763,66
EAPR,FSM,Micronesia (Federated States of),2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1167,667,57
EAPR,FSM,Micronesia (Federated States of),2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,57
EAPR,FSM,Micronesia (Federated States of),2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,2328,856,37
Industrialized,GBR,United Kingdom,2010,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,359789,308123,86
Industrialized,GBR,United Kingdom,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,356506,316043,89
Industrialized,GBR,United Kingdom,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,352281,319277,91
Industrialized,GBR,United Kingdom,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,347809,311470,90
Industrialized,GBR,United Kingdom,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,341836,308131,90
Industrialized,GBR,United Kingdom,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,88
Industrialized,GBR,United Kingdom,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,347625,298180,86
Industrialized,GBR,United Kingdom,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,360232,308043,86
Industrialized,GBR,United Kingdom,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,370905,314512,85
Industrialized,GBR,United Kingdom,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,380753,325014,85
Industrialized,GBR,United Kingdom,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,388836,330528,85
Industrialized,GBR,United Kingdom,2010,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,359789,280220,78
Industrialized,GBR,United Kingdom,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,356506,297561,83
Industrialized,GBR,United Kingdom,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,352281,306095,87
Industrialized,GBR,United Kingdom,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,347809,293714,84
Industrialized,GBR,United Kingdom,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,341836,289947,85
Industrialized,GBR,United Kingdom,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,84
Industrialized,GBR,United Kingdom,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,342352,285381,83
Industrialized,GBR,United Kingdom,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,350228,286466,82
Industrialized,GBR,United Kingdom,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,362130,297610,82
Industrialized,GBR,United Kingdom,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,372156,305167,82
Industrialized,GBR,United Kingdom,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,381510,245397,64
Industrialized,GBR,United Kingdom,2012,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,373112,320127,86
Industrialized,GBR,United Kingdom,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,369276,308123,83
Industrialized,GBR,United Kingdom,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,363720,316043,87
Industrialized,GBR,United Kingdom,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,357288,319277,89
Industrialized,GBR,United Kingdom,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,353836,311470,88
Industrialized,GBR,United Kingdom,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,349047,308131,88
Industrialized,GBR,United Kingdom,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,86
Industrialized,GBR,United Kingdom,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,354991,298180,84
Industrialized,GBR,United Kingdom,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,365297,308043,84
Industrialized,GBR,United Kingdom,2012,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,373112,319744,86
Industrialized,GBR,United Kingdom,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,369276,280220,76
Industrialized,GBR,United Kingdom,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,363720,297561,82
Industrialized,GBR,United Kingdom,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,357288,306095,86
Industrialized,GBR,United Kingdom,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,353836,293714,83
Industrialized,GBR,United Kingdom,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,349047,289947,83
Industrialized,GBR,United Kingdom,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,348586,285381,82
Industrialized,GBR,United Kingdom,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,354991,286466,81
Industrialized,GBR,United Kingdom,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,365297,297610,81
CEECIS,GEO,Georgia,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,72130,27210,38
CEECIS,GEO,Georgia,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,47477,8955,19
CEECIS,GEO,Georgia,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,72130,8088,11
CEECIS,GEO,Georgia,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,66599,14474,22
WCAR,GMB,Gambia,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,176216,119406,68
LACR,GRD,Grenada,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,874,642,73
LACR,GRD,Grenada,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,879,502,57
LACR,GRD,Grenada,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,874,359,41
LACR,GRD,Grenada,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,879,280,32
LACR,GTM,Guatemala,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,376578,189686,50
LACR,GTM,Guatemala,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,374348,158723,42
LACR,GTM,Guatemala,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,376578,115463,31
LACR,GTM,Guatemala,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,448571,106871,24
LACR,GUY,Guyana,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,33377,4327,13
LACR,GUY,Guyana,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,28331,4774,17
LACR,GUY,Guyana,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,22868,1323,6
LACR,GUY,Guyana,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,25161,572,2
LACR,GUY,Guyana,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,22346,3216,14
LACR,GUY,Guyana,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,21621,6539,30
LACR,GUY,Guyana,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,35231,9125,26
LACR,GUY,Guyana,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,32880,10179,31
LACR,GUY,Guyana,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,33377,624,2
LACR,GUY,Guyana,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,32034,2832,9
LACR,GUY,Guyana,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,28513,1218,4
LACR,GUY,Guyana,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,27208,728,3
LACR,GUY,Guyana,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,22346,1829,8
LACR,GUY,Guyana,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,21621,2705,13
LACR,GUY,Guyana,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,35231,3214,9
LACR,GUY,Guyana,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,38791,5154,13
LACR,GUY,Guyana,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,34220,5125,15
LACR,GUY,Guyana,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,7228,2425,34
LACR,GUY,Guyana,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,7228,922,13
LACR,HND,Honduras,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,102300,77622,76
LACR,HND,Honduras,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,101809,73659,72
LACR,HND,Honduras,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,101265,91712,91
LACR,HND,Honduras,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,100613,78790,78
LACR,HND,Honduras,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,99696,67197,67
LACR,HND,Honduras,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,102300,54182,53
LACR,HND,Honduras,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,101809,63245,62
LACR,HND,Honduras,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,101265,53703,53
LACR,HND,Honduras,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,100613,59446,59
LACR,HND,Honduras,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,99696,46849,47
LACR,HND,Honduras,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,101787,77622,76
LACR,HND,Honduras,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,101787,54182,53
Industrialized,HUN,Hungary,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,46855,35284,75
Industrialized,HUN,Hungary,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,46725,33847,72
Industrialized,HUN,Hungary,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,46860,33876,72
Industrialized,HUN,Hungary,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,47049,33526,71
Industrialized,HUN,Hungary,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,47266,36970,78
Industrialized,HUN,Hungary,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,47655,41012,86
Industrialized,HUN,Hungary,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,46858,35138,75
Industrialized,HUN,Hungary,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,46818,33702,72
Industrialized,HUN,Hungary,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,46910,33769,72
Industrialized,HUN,Hungary,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,47074,33444,71
Industrialized,HUN,Hungary,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,47308,36857,78
Industrialized,HUN,Hungary,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,47038,35284,75
Industrialized,HUN,Hungary,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,46930,33847,72
Industrialized,HUN,Hungary,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,46990,33876,72
Industrialized,HUN,Hungary,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,47038,35138,75
Industrialized,HUN,Hungary,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,46930,33702,72
Industrialized,HUN,Hungary,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,46990,33769,72
EAPR,IDN,Indonesia,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,2238460,116162,5
EAPR,IDN,Indonesia,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,2220946,122500,6
EAPR,IDN,Indonesia,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,2214045,134175,6
EAPR,IDN,Indonesia,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,2238006,180876,8
EAPR,IDN,Indonesia,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,2238460,70915,3
EAPR,IDN,Indonesia,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,2220946,101459,5
EAPR,IDN,Indonesia,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,2214045,125444,6
EAPR,IDN,Indonesia,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,2238006,165378,7
Industrialized,IRL,Ireland,2010,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,84
Industrialized,IRL,Ireland,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,84
Industrialized,IRL,Ireland,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,28399,26364,93
Industrialized,IRL,Ireland,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,28723,26869,94
Industrialized,IRL,Ireland,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,29076,27497,95
Industrialized,IRL,Ireland,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,29719,26154,88
Industrialized,IRL,Ireland,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,30796,17095,56
Industrialized,IRL,Ireland,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,32117,21615,67
Industrialized,IRL,Ireland,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,33330,23464,70
Industrialized,IRL,Ireland,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,34470,29213,85
Industrialized,IRL,Ireland,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,35314,21352,60
Industrialized,IRL,Ireland,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,82
Industrialized,IRL,Ireland,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,28399,25387,89
Industrialized,IRL,Ireland,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,28723,25438,89
Industrialized,IRL,Ireland,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,29076,25435,87
Industrialized,IRL,Ireland,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,29719,26856,90
Industrialized,IRL,Ireland,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,30796,22951,75
Industrialized,IRL,Ireland,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,32117,16942,53
Industrialized,IRL,Ireland,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,33330,20719,62
Industrialized,IRL,Ireland,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,34470,23758,69
Industrialized,IRL,Ireland,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,35314,27318,77
Industrialized,IRL,Ireland,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,27806,25866,93
Industrialized,IRL,Ireland,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,28134,26534,94
Industrialized,IRL,Ireland,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,28695,27334,95
Industrialized,IRL,Ireland,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,29240,27307,93
Industrialized,IRL,Ireland,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,30021,23332,78
Industrialized,IRL,Ireland,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,31143,20574,66
Industrialized,IRL,Ireland,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,32400,22732,70
Industrialized,IRL,Ireland,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,27806,20131,72
Industrialized,IRL,Ireland,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,28134,25508,91
Industrialized,IRL,Ireland,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,28695,25654,89
Industrialized,IRL,Ireland,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,29240,27381,94
Industrialized,IRL,Ireland,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,30021,23674,79
Industrialized,IRL,Ireland,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,31143,18595,60
Industrialized,IRL,Ireland,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,32400,20882,64
Industrialized,ISL,Iceland,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,4195,3854,92
Industrialized,ISL,Iceland,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,2089,1944,93
Industrialized,ISL,Iceland,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,2086,1833,88
Industrialized,ISL,Iceland,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,2080,1897,91
Industrialized,ISL,Iceland,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,2086,1834,88
Industrialized,ISL,Iceland,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,2115,1990,94
Industrialized,ISL,Iceland,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,2156,1931,90
Industrialized,ISL,Iceland,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,2194,2057,94
Industrialized,ISL,Iceland,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,2297,2164,94
Industrialized,ISL,Iceland,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,4196,3875,92
Industrialized,ISL,Iceland,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,2087,1887,90
Industrialized,ISL,Iceland,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,2083,1858,89
Industrialized,ISL,Iceland,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,2076,1827,88
Industrialized,ISL,Iceland,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,2089,1895,91
Industrialized,ISL,Iceland,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,2119,1877,89
Industrialized,ISL,Iceland,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,2159,1835,85
Industrialized,ISL,Iceland,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,2256,2099,93
Industrialized,ISL,Iceland,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,2108,1742,83
Industrialized,ISL,Iceland,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,2081,2112,99
Industrialized,ISL,Iceland,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,2083,1944,93
Industrialized,ISL,Iceland,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,2085,1833,88
Industrialized,ISL,Iceland,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,2085,1897,91
Industrialized,ISL,Iceland,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,2098,1834,87
Industrialized,ISL,Iceland,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,2127,1990,94
Industrialized,ISL,Iceland,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,2108,1907,90
Industrialized,ISL,Iceland,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,2081,1968,95
Industrialized,ISL,Iceland,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,2083,1887,91
Industrialized,ISL,Iceland,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,2085,1858,89
Industrialized,ISL,Iceland,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,2085,1827,88
Industrialized,ISL,Iceland,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,2098,1895,90
Industrialized,ISL,Iceland,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,2127,1877,88
Industrialized,ISR,Israel,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,68083,37033,54
Industrialized,ISR,Israel,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,68654,43188,63
Industrialized,ISR,Israel,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,71178,43891,62
Industrialized,ISR,Israel,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,74328,38889,52
Industrialized,ISR,Israel,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,74066,40679,55
Industrialized,ISR,Israel,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,73869,42901,58
Industrialized,ISR,Israel,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,76039,46720,61
Industrialized,ISR,Israel,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,68083,34620,51
Industrialized,ISR,Israel,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,68654,35743,52
Industrialized,ISR,Israel,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,71178,40797,57
Industrialized,ISR,Israel,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,74328,36882,50
Industrialized,ISR,Israel,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,74066,38365,52
Industrialized,ISR,Israel,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,73869,39699,54
Industrialized,ISR,Israel,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,76039,41512,55
Industrialized,ISR,Israel,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,68083,43188,63
Industrialized,ISR,Israel,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,68654,43891,64
Industrialized,ISR,Israel,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,71178,38889,55
Industrialized,ISR,Israel,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,74328,40679,55
Industrialized,ISR,Israel,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,55
Industrialized,ISR,Israel,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,68083,34620,51
Industrialized,ISR,Israel,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,68654,35743,52
Industrialized,ISR,Israel,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,71178,40797,57
Industrialized,ISR,Israel,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,74328,36882,50
Industrialized,ISR,Israel,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,74066,38365,52
Industrialized,ITA,Italy,2010,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,265025,150563,57
Industrialized,ITA,Italy,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,265828,183872,69
Industrialized,ITA,Italy,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,267803,193048,72
Industrialized,ITA,Italy,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,269769,189182,70
Industrialized,ITA,Italy,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,271592,177247,65
Industrialized,ITA,Italy,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,273277,182097,67
Industrialized,ITA,Italy,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,275828,180418,65
Industrialized,ITA,Italy,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,277631,176163,63
Industrialized,ITA,Italy,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,278726,170343,61
Industrialized,ITA,Italy,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,279384,171591,61
Industrialized,ITA,Italy,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,278887,124428,45
Industrialized,ITA,Italy,2010,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,265025,119323,45
Industrialized,ITA,Italy,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,265828,141827,53
Industrialized,ITA,Italy,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,267803,149992,56
Industrialized,ITA,Italy,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,269769,152397,56
Industrialized,ITA,Italy,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,271592,136690,50
Industrialized,ITA,Italy,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,273277,153727,56
Industrialized,ITA,Italy,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,275828,147398,53
Industrialized,ITA,Italy,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,277631,136609,49
Industrialized,ITA,Italy,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,278726,111107,40
Industrialized,ITA,Italy,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,279384,145051,52
Industrialized,ITA,Italy,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,278887,75663,27
Industrialized,ITA,Italy,2010,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,272025,33166,12
Industrialized,ITA,Italy,2011,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,270911,112256,41
Industrialized,ITA,Italy,2012,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,269279,197179,73
Industrialized,ITA,Italy,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,268132,196558,73
Industrialized,ITA,Italy,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,268411,195773,73
Industrialized,ITA,Italy,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,269849,206774,77
Industrialized,ITA,Italy,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,272857,203718,75
Industrialized,ITA,Italy,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,274987,199422,73
Industrialized,ITA,Italy,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,276604,202553,73
Industrialized,ITA,Italy,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,277886,184331,66
Industrialized,ITA,Italy,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,278827,182132,65
Industrialized,ITA,Italy,2010,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,272025,26247,10
Industrialized,ITA,Italy,2011,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,270911,104011,38
Industrialized,ITA,Italy,2012,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,269279,182976,68
Industrialized,ITA,Italy,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,268132,184187,69
Industrialized,ITA,Italy,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,268411,186179,69
Industrialized,ITA,Italy,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,269849,198437,74
Industrialized,ITA,Italy,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,272857,189860,70
Industrialized,ITA,Italy,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,274987,181634,66
Industrialized,ITA,Italy,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,276604,186316,67
Industrialized,ITA,Italy,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,277886,171284,62
Industrialized,ITA,Italy,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,278827,167166,60
LACR,JAM,Jamaica,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,23023,5391,23
LACR,JAM,Jamaica,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,22677,5505,24
LACR,JAM,Jamaica,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,22354,5140,23
LACR,JAM,Jamaica,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,22173,1856,8
LACR,JAM,Jamaica,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,22948,1834,8
LACR,JAM,Jamaica,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,67792,6146,9
LACR,JAM,Jamaica,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,22290,771,3
LACR,JAM,Jamaica,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,23108,1043,5
LACR,JAM,Jamaica,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,22786,4804,21
LACR,JAM,Jamaica,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,23108,145,1
LACR,JAM,Jamaica,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,22786,1253,5
Industrialized,JPN,Japan,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,570130,98656,17
Industrialized,JPN,Japan,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,562871,3879,1
Industrialized,JPN,Japan,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,554965,2697,1
Industrialized,JPN,Japan,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,550089,1834,0
Industrialized,JPN,Japan,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,548160,3347,1
Industrialized,JPN,Japan,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,570130,87233,15
Industrialized,JPN,Japan,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,562871,6223,1
Industrialized,JPN,Japan,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,554965,2792,1
Industrialized,JPN,Japan,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,550089,1782,0
Industrialized,JPN,Japan,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,548160,1847,0
Industrialized,JPN,Japan,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,547695,1782,0
Industrialized,JPN,Japan,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,546024,1847,0
Industrialized,JPN,Japan,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,543030,4184,1
Industrialized,JPN,Japan,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,579137,8518,1
Industrialized,JPN,Japan,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,570623,51531,9
Industrialized,JPN,Japan,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,563641,31467,6
Industrialized,JPN,Japan,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,556930,4346,1
Industrialized,JPN,Japan,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,579137,29858,5
Industrialized,JPN,Japan,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,570623,36761,6
Industrialized,JPN,Japan,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,563641,10798,2
Industrialized,JPN,Japan,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,556930,1907,0
Industrialized,JPN,Japan,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,552031,885,0
Industrialized,JPN,Japan,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,549570,483,0
Industrialized,JPN,Japan,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,548145,1910,0
ESAR,KEN,Kenya,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,680422,170045,25
ESAR,KEN,Kenya,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,683825,228698,33
ESAR,KEN,Kenya,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,679701,111920,16
LACR,KNA,Saint Kitts and Nevis,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,386,349,90
EAPR,KOR,Republic of Korea,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,455498,232467,51
EAPR,KOR,Republic of Korea,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,354560,108361,31
EAPR,KOR,Republic of Korea,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,378071,287373,76
EAPR,KOR,Republic of Korea,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,308985,221604,72
EAPR,KOR,Republic of Korea,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,455806,225459,49
EAPR,KOR,Republic of Korea,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,353582,226184,64
EAPR,KOR,Republic of Korea,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,299653,156201,52
EAPR,KOR,Republic of Korea,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,231052,145329,63
EAPR,KOR,Republic of Korea,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,224910,165898,74
EAPR,KOR,Republic of Korea,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,231052,108658,47
EAPR,KOR,Republic of Korea,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,224910,144641,64
EAPR,LAO,Lao People's Democratic Republic,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,372415,284056,76
WCAR,LBR,Liberia,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,63576,8970,14
WCAR,LBR,Liberia,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,64383,27167,42
WCAR,LBR,Liberia,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,64383,11326,18
LACR,LCA,Saint Lucia,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1086,934,86
LACR,LCA,Saint Lucia,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1086,497,46
ROSA,LKA,Sri Lanka,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,173317,117071,68
ROSA,LKA,Sri Lanka,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,345831,300809,87
ROSA,LKA,Sri Lanka,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,173130,172054,99
ROSA,LKA,Sri Lanka,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,170338,119977,70
ROSA,LKA,Sri Lanka,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,345831,199579,58
ROSA,LKA,Sri Lanka,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,173130,142761,82
ROSA,LKA,Sri Lanka,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,170338,87420,51
Industrialized,LTU,Lithuania,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,12765,2337,18
Industrialized,LTU,Lithuania,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,15280,5275,35
Industrialized,LTU,Lithuania,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,12587,6966,55
Industrialized,LTU,Lithuania,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,14094,9071,64
Industrialized,LTU,Lithuania,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,15230,9388,62
Industrialized,LTU,Lithuania,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,14697,4070,28
Industrialized,LTU,Lithuania,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,12484,8135,65
Industrialized,LTU,Lithuania,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,13409,8816,66
Industrialized,LTU,Lithuania,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,14401,9731,68
Industrialized,LTU,Lithuania,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,11517,6348,55
Industrialized,LTU,Lithuania,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,11517,4070,35
Industrialized,LUX,Luxembourg,2010,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,6532,1230,19
Industrialized,LUX,Luxembourg,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,7285,1603,22
Industrialized,LUX,Luxembourg,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,7225,1689,23
Industrialized,LUX,Luxembourg,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,7000,1704,24
Industrialized,LUX,Luxembourg,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,6879,1741,25
Industrialized,LUX,Luxembourg,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,6769,2498,37
Industrialized,LUX,Luxembourg,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,37
Industrialized,LUX,Luxembourg,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,37
Industrialized,LUX,Luxembourg,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,37
Industrialized,LUX,Luxembourg,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,37
Industrialized,LUX,Luxembourg,2010,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,6741,1084,16
Industrialized,LUX,Luxembourg,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,7471,1442,19
Industrialized,LUX,Luxembourg,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,7414,1494,20
Industrialized,LUX,Luxembourg,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,7222,1461,20
Industrialized,LUX,Luxembourg,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,7166,694,10
Industrialized,LUX,Luxembourg,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,7835,1108,14
Industrialized,LUX,Luxembourg,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,14
Industrialized,LUX,Luxembourg,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,14
Industrialized,LUX,Luxembourg,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,14
Industrialized,LUX,Luxembourg,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,14
Industrialized,LUX,Luxembourg,2010,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,2971,1500,50
Industrialized,LUX,Luxembourg,2011,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,3069,1782,58
Industrialized,LUX,Luxembourg,2012,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,3155,1451,46
Industrialized,LUX,Luxembourg,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,3208,1456,45
Industrialized,LUX,Luxembourg,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,3219,1621,50
Industrialized,LUX,Luxembourg,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,3201,1684,53
Industrialized,LUX,Luxembourg,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,3219,1945,60
Industrialized,LUX,Luxembourg,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,60
Industrialized,LUX,Luxembourg,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,60
Industrialized,LUX,Luxembourg,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,60
Industrialized,LUX,Luxembourg,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,60
Industrialized,LUX,Luxembourg,2010,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,2971,1308,44
Industrialized,LUX,Luxembourg,2011,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,3069,1613,53
Industrialized,LUX,Luxembourg,2012,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,3155,1293,41
Industrialized,LUX,Luxembourg,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,3208,1294,40
Industrialized,LUX,Luxembourg,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,3219,1443,45
Industrialized,LUX,Luxembourg,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,3201,1416,44
Industrialized,LUX,Luxembourg,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,3219,1376,43
Industrialized,LUX,Luxembourg,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,43
Industrialized,LUX,Luxembourg,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,43
Industrialized,LUX,Luxembourg,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,43
Industrialized,LUX,Luxembourg,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,43
Industrialized,LVA,Latvia,2010,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,7946,4203,53
Industrialized,LVA,Latvia,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,7908,5269,67
Industrialized,LVA,Latvia,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,8296,5110,62
Industrialized,LVA,Latvia,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,8605,5228,61
Industrialized,LVA,Latvia,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,8897,4464,50
Industrialized,LVA,Latvia,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,9179,4465,49
Industrialized,LVA,Latvia,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,9425,3984,42
Industrialized,LVA,Latvia,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,9600,4607,48
Industrialized,LVA,Latvia,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,9801,5062,52
Industrialized,LVA,Latvia,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,10098,5438,54
Industrialized,LVA,Latvia,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,10237,6226,61
Industrialized,LVA,Latvia,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,7908,5188,66
Industrialized,LVA,Latvia,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,8296,4653,56
Industrialized,LVA,Latvia,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,8605,5069,59
Industrialized,LVA,Latvia,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,8897,4783,54
Industrialized,LVA,Latvia,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,9179,4221,46
Industrialized,LVA,Latvia,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,9425,3611,38
Industrialized,LVA,Latvia,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,9600,3738,39
Industrialized,LVA,Latvia,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,9801,4385,45
Industrialized,LVA,Latvia,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,10098,5189,51
Industrialized,LVA,Latvia,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,10237,5867,57
Industrialized,LVA,Latvia,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,7961,4203,53
Industrialized,LVA,Latvia,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,7914,5269,67
Industrialized,LVA,Latvia,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,8232,5110,62
Industrialized,LVA,Latvia,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,8306,5228,63
Industrialized,LVA,Latvia,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,8546,4464,52
Industrialized,LVA,Latvia,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,8892,4465,50
Industrialized,LVA,Latvia,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,9173,3984,43
Industrialized,LVA,Latvia,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,9346,4607,49
Industrialized,LVA,Latvia,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,7914,5188,66
Industrialized,LVA,Latvia,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,8232,4653,57
Industrialized,LVA,Latvia,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,8306,5069,61
Industrialized,LVA,Latvia,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,8546,4783,56
Industrialized,LVA,Latvia,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,8892,4221,47
Industrialized,LVA,Latvia,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,9173,3611,39
Industrialized,LVA,Latvia,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,9346,3738,40
CEECIS,MDA,Republic of Moldova,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,42079,22591,54
CEECIS,MDA,Republic of Moldova,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,49
CEECIS,MDA,Republic of Moldova,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,21537,9556,44
CEECIS,MDA,Republic of Moldova,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,42079,18116,43
CEECIS,MDA,Republic of Moldova,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,21552,6767,31
CEECIS,MDA,Republic of Moldova,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,21537,8511,40
ROSA,MDV,Maldives,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,15451,13596,88
ROSA,MDV,Maldives,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,3449,2414,70
ROSA,MDV,Maldives,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,3449,2339,68
LACR,MEX,Mexico,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1110982,890372,80
LACR,MEX,Mexico,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1112566,1209060,99
LACR,MEX,Mexico,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1110210,1118386,99
LACR,MEX,Mexico,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1103517,1090430,99
LACR,MEX,Mexico,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1097746,1125844,99
LACR,MEX,Mexico,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1092316,1093638,99
LACR,MEX,Mexico,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1088092,1024277,94
LACR,MEX,Mexico,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,94
LACR,MEX,Mexico,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1107867,921445,83
LACR,MEX,Mexico,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1110960,1028857,93
LACR,MEX,Mexico,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1112620,1095082,98
LACR,MEX,Mexico,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1109630,1054302,95
LACR,MEX,Mexico,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1102715,1199126,99
LACR,MEX,Mexico,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1097144,1062929,97
LACR,MEX,Mexico,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1091394,1045892,96
LACR,MEX,Mexico,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1087041,1036455,95
LACR,MEX,Mexico,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1087350,261182,24
LACR,MEX,Mexico,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,1095346,82598,8
LACR,MEX,Mexico,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,1100443,121410,11
LACR,MEX,Mexico,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,1104289,156189,14
LACR,MEX,Mexico,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,1108431,1552981,99
LACR,MEX,Mexico,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,1109665,1209060,99
LACR,MEX,Mexico,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,1106054,1157190,99
LACR,MEX,Mexico,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,1099485,1166191,99
LACR,MEX,Mexico,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,1095346,155779,14
LACR,MEX,Mexico,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,1100443,121410,11
LACR,MEX,Mexico,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,1104289,122222,11
LACR,MEX,Mexico,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,1108431,1307225,99
LACR,MEX,Mexico,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,1109665,1033516,93
LACR,MEX,Mexico,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,1106054,1149897,99
LACR,MEX,Mexico,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,1099485,1148534,99
EAPR,MHL,Marshall Islands,2010,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,785,235,30
EAPR,MHL,Marshall Islands,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,766,154,20
EAPR,MHL,Marshall Islands,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,784,89,11
EAPR,MHL,Marshall Islands,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,800,367,46
EAPR,MHL,Marshall Islands,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,812,249,31
EAPR,MHL,Marshall Islands,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,827,725,88
EAPR,MHL,Marshall Islands,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,841,175,21
EAPR,MHL,Marshall Islands,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,842,564,67
EAPR,MHL,Marshall Islands,2010,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,785,358,46
EAPR,MHL,Marshall Islands,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,766,23,3
EAPR,MHL,Marshall Islands,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,784,82,10
EAPR,MHL,Marshall Islands,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,800,110,14
EAPR,MHL,Marshall Islands,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,812,185,23
EAPR,MHL,Marshall Islands,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,827,258,31
EAPR,MHL,Marshall Islands,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,841,178,21
EAPR,MHL,Marshall Islands,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,842,237,28
EAPR,MHL,Marshall Islands,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,842,201,24
EAPR,MHL,Marshall Islands,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,744,248,33
EAPR,MHL,Marshall Islands,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,763,67,9
EAPR,MHL,Marshall Islands,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,755,141,19
EAPR,MHL,Marshall Islands,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,746,195,26
EAPR,MHL,Marshall Islands,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,763,333,44
EAPR,MHL,Marshall Islands,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,779,337,43
EAPR,MHL,Marshall Islands,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,792,406,51
EAPR,MHL,Marshall Islands,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,744,369,50
EAPR,MHL,Marshall Islands,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,763,36,5
EAPR,MHL,Marshall Islands,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,755,83,11
EAPR,MHL,Marshall Islands,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,746,82,11
EAPR,MHL,Marshall Islands,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,763,161,21
EAPR,MHL,Marshall Islands,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,779,186,24
EAPR,MHL,Marshall Islands,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,792,156,20
CEECIS,MKD,Republic of North Macedonia,2010,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,12997,6100,47
CEECIS,MKD,Republic of North Macedonia,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,12659,6681,53
CEECIS,MKD,Republic of North Macedonia,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,12446,5259,42
CEECIS,MKD,Republic of North Macedonia,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,12228,6342,52
CEECIS,MKD,Republic of North Macedonia,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,12063,4870,40
CEECIS,MKD,Republic of North Macedonia,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,11896,5755,48
CEECIS,MKD,Republic of North Macedonia,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,11644,5117,44
CEECIS,MKD,Republic of North Macedonia,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,11350,5004,44
CEECIS,MKD,Republic of North Macedonia,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,11109,5051,45
CEECIS,MKD,Republic of North Macedonia,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,45
CEECIS,MKD,Republic of North Macedonia,2010,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,12997,4293,33
CEECIS,MKD,Republic of North Macedonia,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,12659,6055,48
CEECIS,MKD,Republic of North Macedonia,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,12446,3854,31
CEECIS,MKD,Republic of North Macedonia,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,12228,4202,34
CEECIS,MKD,Republic of North Macedonia,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,12063,5619,47
CEECIS,MKD,Republic of North Macedonia,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,11896,3677,31
CEECIS,MKD,Republic of North Macedonia,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,11644,5170,44
CEECIS,MKD,Republic of North Macedonia,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,11350,4325,38
CEECIS,MKD,Republic of North Macedonia,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,11109,4464,40
CEECIS,MKD,Republic of North Macedonia,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,40
CEECIS,MKD,Republic of North Macedonia,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,12737,6100,48
CEECIS,MKD,Republic of North Macedonia,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,12401,6681,54
CEECIS,MKD,Republic of North Macedonia,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,12220,3854,32
CEECIS,MKD,Republic of North Macedonia,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,12088,6342,52
CEECIS,MKD,Republic of North Macedonia,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,12000,4870,41
CEECIS,MKD,Republic of North Macedonia,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,11868,5755,48
CEECIS,MKD,Republic of North Macedonia,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,11631,5117,44
CEECIS,MKD,Republic of North Macedonia,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,12737,4293,34
CEECIS,MKD,Republic of North Macedonia,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,12401,6055,49
CEECIS,MKD,Republic of North Macedonia,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,12220,5259,43
CEECIS,MKD,Republic of North Macedonia,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,12088,4202,35
CEECIS,MKD,Republic of North Macedonia,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,12000,5619,47
CEECIS,MKD,Republic of North Macedonia,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,11868,3677,31
CEECIS,MKD,Republic of North Macedonia,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,11631,5170,44
Industrialized,MLT,Malta,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,4181,2747,66
Industrialized,MLT,Malta,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,2788,2481,89
Industrialized,MLT,Malta,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1926,1702,88
Industrialized,MLT,Malta,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1919,1603,84
Industrialized,MLT,Malta,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1931,1652,86
Industrialized,MLT,Malta,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1939,1676,86
Industrialized,MLT,Malta,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1948,1676,86
Industrialized,MLT,Malta,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,97
Industrialized,MLT,Malta,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,4181,1185,28
Industrialized,MLT,Malta,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,3513,3049,87
Industrialized,MLT,Malta,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1926,1688,88
Industrialized,MLT,Malta,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1919,1601,83
Industrialized,MLT,Malta,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1931,1513,78
Industrialized,MLT,Malta,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1939,1557,80
Industrialized,MLT,Malta,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1948,1587,81
Industrialized,MLT,Malta,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1961,1674,85
Industrialized,MLT,Malta,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,2153,1498,70
Industrialized,MLT,Malta,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,75
Industrialized,MLT,Malta,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,81
Industrialized,MLT,Malta,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,1961,1702,87
Industrialized,MLT,Malta,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,1942,1603,83
Industrialized,MLT,Malta,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,1945,1652,85
Industrialized,MLT,Malta,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,2153,661,31
Industrialized,MLT,Malta,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,49
Industrialized,MLT,Malta,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,68
Industrialized,MLT,Malta,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,1961,1688,86
Industrialized,MLT,Malta,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,1942,1601,82
Industrialized,MLT,Malta,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,1945,1632,84
EAPR,MMR,Myanmar,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,459856,456831,99
ESAR,MUS,Mauritius,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,8207,6334,77
ESAR,MUS,Mauritius,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,7878,7151,91
ESAR,MUS,Mauritius,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,7588,6546,86
ESAR,MUS,Mauritius,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,7352,6192,84
ESAR,MUS,Mauritius,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,7137,5881,82
ESAR,MUS,Mauritius,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,16076,12355,77
ESAR,MUS,Mauritius,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,7588,6134,81
ESAR,MUS,Mauritius,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,7352,5887,80
ESAR,MUS,Mauritius,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,7137,5315,74
ESAR,MWI,Malawi,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,264638,233229,88
ESAR,MWI,Malawi,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,266223,224839,84
ESAR,MWI,Malawi,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,263704,204111,77
EAPR,MYS,Malaysia,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,274069,228796,83
EAPR,MYS,Malaysia,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,271754,232281,85
EAPR,MYS,Malaysia,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,268255,243530,91
EAPR,MYS,Malaysia,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,264682,226051,85
EAPR,MYS,Malaysia,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,261241,220749,85
EAPR,MYS,Malaysia,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,257488,214904,83
EAPR,MYS,Malaysia,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,252984,243530,96
EAPR,MYS,Malaysia,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,248113,208419,84
EAPR,MYS,Malaysia,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,243346,208500,86
EAPR,MYS,Malaysia,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,238152,209279,88
EAPR,MYS,Malaysia,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,274069,220129,80
EAPR,MYS,Malaysia,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,271754,228666,84
EAPR,MYS,Malaysia,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,268255,241994,90
EAPR,MYS,Malaysia,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,264682,225212,85
EAPR,MYS,Malaysia,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,261241,220005,84
EAPR,MYS,Malaysia,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,257488,213187,83
EAPR,MYS,Malaysia,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,252984,243080,96
EAPR,MYS,Malaysia,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,248113,206562,83
EAPR,MYS,Malaysia,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,243346,207343,85
EAPR,MYS,Malaysia,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,238152,199236,84
EAPR,MYS,Malaysia,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,274749,228796,83
EAPR,MYS,Malaysia,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,272134,232281,85
EAPR,MYS,Malaysia,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,268538,243530,91
EAPR,MYS,Malaysia,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,265292,226051,85
EAPR,MYS,Malaysia,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,262190,220749,84
EAPR,MYS,Malaysia,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,258428,214904,83
EAPR,MYS,Malaysia,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,253738,243530,96
EAPR,MYS,Malaysia,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,248567,208419,84
EAPR,MYS,Malaysia,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,274749,220129,80
EAPR,MYS,Malaysia,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,272134,228666,84
EAPR,MYS,Malaysia,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,268538,241994,90
EAPR,MYS,Malaysia,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,265292,225212,85
EAPR,MYS,Malaysia,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,262190,220005,84
EAPR,MYS,Malaysia,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,258428,213187,82
EAPR,MYS,Malaysia,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,253738,243080,96
EAPR,MYS,Malaysia,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,248567,206562,83
Industrialized,NLD,Netherlands,2010,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,384934,221315,57
Industrialized,NLD,Netherlands,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,95911,59036,62
Industrialized,NLD,Netherlands,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,98354,62838,64
Industrialized,NLD,Netherlands,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,99214,64563,65
Industrialized,NLD,Netherlands,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,102189,68207,67
Industrialized,NLD,Netherlands,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,100139,66293,66
Industrialized,NLD,Netherlands,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,99479,59835,60
Industrialized,NLD,Netherlands,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,99507,52743,53
Industrialized,NLD,Netherlands,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,96895,50675,52
Industrialized,NLD,Netherlands,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,94365,59021,63
Industrialized,NLD,Netherlands,2010,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,379963,198900,52
Industrialized,NLD,Netherlands,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,94795,53076,56
Industrialized,NLD,Netherlands,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,97175,56427,58
Industrialized,NLD,Netherlands,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,97616,57457,59
Industrialized,NLD,Netherlands,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,100210,61159,61
Industrialized,NLD,Netherlands,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,98193,59866,61
Industrialized,NLD,Netherlands,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,97464,52029,53
Industrialized,NLD,Netherlands,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,97017,44189,46
Industrialized,NLD,Netherlands,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,94273,42886,45
Industrialized,NLD,Netherlands,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,94167,49940,53
Industrialized,NLD,Netherlands,2012,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,97230,59036,61
Industrialized,NLD,Netherlands,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,96844,62838,65
Industrialized,NLD,Netherlands,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,97305,64563,66
Industrialized,NLD,Netherlands,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,98287,68207,69
Industrialized,NLD,Netherlands,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,98998,66293,67
Industrialized,NLD,Netherlands,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,98789,59835,61
Industrialized,NLD,Netherlands,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,98012,52743,54
Industrialized,NLD,Netherlands,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,100146,50675,51
Industrialized,NLD,Netherlands,2012,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,97230,53076,55
Industrialized,NLD,Netherlands,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,96844,56427,58
Industrialized,NLD,Netherlands,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,97305,57457,59
Industrialized,NLD,Netherlands,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,98287,61159,62
Industrialized,NLD,Netherlands,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,98998,59866,60
Industrialized,NLD,Netherlands,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,98789,52029,53
Industrialized,NLD,Netherlands,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,98012,44189,45
Industrialized,NLD,Netherlands,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,100146,42886,43
Industrialized,NOR,Norway,2010,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,30771,22000,71
Industrialized,NOR,Norway,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,30552,23500,77
Industrialized,NOR,Norway,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,30317,23905,79
Industrialized,NOR,Norway,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,30106,25323,84
Industrialized,NOR,Norway,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,29841,25767,86
Industrialized,NOR,Norway,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,29732,26244,88
Industrialized,NOR,Norway,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,30183,27603,91
Industrialized,NOR,Norway,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,30709,27832,91
Industrialized,NOR,Norway,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,31054,29093,94
Industrialized,NOR,Norway,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,31310,29048,93
Industrialized,NOR,Norway,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,31424,29064,92
Industrialized,NOR,Norway,2010,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,30771,17600,57
Industrialized,NOR,Norway,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,30552,22100,72
Industrialized,NOR,Norway,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,30317,22223,73
Industrialized,NOR,Norway,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,30106,22489,75
Industrialized,NOR,Norway,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,29841,23773,80
Industrialized,NOR,Norway,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,29732,24316,82
Industrialized,NOR,Norway,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,30183,25252,84
Industrialized,NOR,Norway,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,30709,26124,85
Industrialized,NOR,Norway,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,31054,26765,86
Industrialized,NOR,Norway,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,31310,28437,91
Industrialized,NOR,Norway,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,31424,28406,90
Industrialized,NOR,Norway,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,31346,22098,70
Industrialized,NOR,Norway,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,31094,24722,80
Industrialized,NOR,Norway,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,30791,24186,79
Industrialized,NOR,Norway,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,30820,25084,81
Industrialized,NOR,Norway,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,30680,25802,84
Industrialized,NOR,Norway,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,30648,26651,87
Industrialized,NOR,Norway,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,30858,27866,90
Industrialized,NOR,Norway,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,31183,28386,91
Industrialized,NOR,Norway,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,31346,22632,72
Industrialized,NOR,Norway,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,31094,22614,73
Industrialized,NOR,Norway,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,30791,22935,74
Industrialized,NOR,Norway,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,30820,24194,79
Industrialized,NOR,Norway,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,30680,24877,81
Industrialized,NOR,Norway,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,30648,25869,84
Industrialized,NOR,Norway,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,30858,26725,87
Industrialized,NOR,Norway,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,31183,27322,88
Industrialized,NZL,New Zealand,2010,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,28797,14331,50
Industrialized,NZL,New Zealand,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,28774,15286,53
Industrialized,NZL,New Zealand,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,28817,15632,54
Industrialized,NZL,New Zealand,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,28798,16398,57
Industrialized,NZL,New Zealand,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,28622,16174,57
Industrialized,NZL,New Zealand,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,56
Industrialized,NZL,New Zealand,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,29030,16375,56
Industrialized,NZL,New Zealand,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,29761,19098,64
Industrialized,NZL,New Zealand,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,30406,18936,62
Industrialized,NZL,New Zealand,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,31079,22170,71
Industrialized,NZL,New Zealand,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,31592,22031,70
Industrialized,NZL,New Zealand,2010,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,28797,13136,46
Industrialized,NZL,New Zealand,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,28774,12790,44
Industrialized,NZL,New Zealand,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,28817,15799,55
Industrialized,NZL,New Zealand,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,28798,16529,57
Industrialized,NZL,New Zealand,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,28622,16856,59
Industrialized,NZL,New Zealand,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,59
Industrialized,NZL,New Zealand,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,29030,17367,60
Industrialized,NZL,New Zealand,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,29761,16713,56
Industrialized,NZL,New Zealand,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,30406,17650,58
Industrialized,NZL,New Zealand,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,31079,20819,67
Industrialized,NZL,New Zealand,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,31592,21252,67
Industrialized,NZL,New Zealand,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,30014,14847,49
Industrialized,NZL,New Zealand,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,29957,15836,53
Industrialized,NZL,New Zealand,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,29844,16458,55
Industrialized,NZL,New Zealand,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,29541,19240,65
Industrialized,NZL,New Zealand,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,29154,18996,65
Industrialized,NZL,New Zealand,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,68
Industrialized,NZL,New Zealand,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,29466,20936,71
Industrialized,NZL,New Zealand,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,30151,23319,77
Industrialized,NZL,New Zealand,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,30014,13776,46
Industrialized,NZL,New Zealand,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,29957,13409,45
Industrialized,NZL,New Zealand,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,29844,16653,56
Industrialized,NZL,New Zealand,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,29541,17550,59
Industrialized,NZL,New Zealand,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,29154,17707,61
Industrialized,NZL,New Zealand,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,29071,16934,58
Industrialized,NZL,New Zealand,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,29466,19574,66
Industrialized,NZL,New Zealand,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,30151,18789,62
LACR,PAN,Panama,2010,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,33961,34552,99
LACR,PAN,Panama,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,34100,30633,90
LACR,PAN,Panama,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,34238,33297,97
LACR,PAN,Panama,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,34392,29001,84
LACR,PAN,Panama,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,34634,29800,86
LACR,PAN,Panama,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,34979,30266,87
LACR,PAN,Panama,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,35345,38430,99
LACR,PAN,Panama,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,35691,29101,82
LACR,PAN,Panama,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,36038,31137,86
LACR,PAN,Panama,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,36403,31003,85
LACR,PAN,Panama,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,36774,24472,67
LACR,PAN,Panama,2010,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,33961,21999,65
LACR,PAN,Panama,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,34100,26882,79
LACR,PAN,Panama,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,34238,26687,78
LACR,PAN,Panama,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,34392,25711,75
LACR,PAN,Panama,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,34634,28004,81
LACR,PAN,Panama,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,34979,20342,58
LACR,PAN,Panama,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,35345,27075,77
LACR,PAN,Panama,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,35691,25451,71
LACR,PAN,Panama,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,36038,24698,69
LACR,PAN,Panama,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,36403,26706,73
LACR,PAN,Panama,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,36774,16345,44
LACR,PAN,Panama,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,34162,34552,99
LACR,PAN,Panama,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,34352,30633,89
LACR,PAN,Panama,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,34544,33297,96
LACR,PAN,Panama,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,34786,29001,83
LACR,PAN,Panama,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,35099,29800,85
LACR,PAN,Panama,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,35434,30266,85
LACR,PAN,Panama,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,34162,21999,64
LACR,PAN,Panama,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,34352,26882,78
LACR,PAN,Panama,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,34544,26687,77
LACR,PAN,Panama,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,34786,25711,74
LACR,PAN,Panama,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,35099,28004,80
LACR,PAN,Panama,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,35434,20342,57
LACR,PER,Peru,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,276086,218,0
LACR,PER,Peru,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,273205,321,0
LACR,PER,Peru,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,272175,521,0
LACR,PER,Peru,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,274616,148050,54
LACR,PER,Peru,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,280525,203661,73
LACR,PER,Peru,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,459556,374841,82
LACR,PER,Peru,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,283927,196569,69
LACR,PER,Peru,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,285389,199681,70
LACR,PER,Peru,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,281355,231249,82
LACR,PER,Peru,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,272175,152,0
LACR,PER,Peru,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,274616,4621,2
LACR,PER,Peru,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,553677,285963,52
LACR,PER,Peru,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,472648,242995,51
LACR,PER,Peru,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,453426,256797,57
LACR,PER,Peru,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,285389,183613,64
LACR,PER,Peru,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,281355,212841,76
LACR,PER,Peru,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,266787,10423,4
LACR,PER,Peru,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,260561,50192,19
LACR,PER,Peru,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,254472,127140,50
LACR,PER,Peru,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,253410,167492,66
LACR,PER,Peru,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,266787,7062,3
LACR,PER,Peru,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,260561,25017,10
LACR,PER,Peru,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,254472,91027,36
LACR,PER,Peru,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,253410,177411,70
EAPR,PHL,Philippines,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1047261,292480,28
EAPR,PHL,Philippines,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1056214,358870,34
EAPR,PHL,Philippines,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1066454,293046,27
EAPR,PHL,Philippines,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1078915,155411,14
EAPR,PHL,Philippines,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1092700,253224,23
EAPR,PHL,Philippines,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,1103957,250636,23
EAPR,PHL,Philippines,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1047261,246313,24
EAPR,PHL,Philippines,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1056214,252774,24
EAPR,PHL,Philippines,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1066454,38024,4
EAPR,PHL,Philippines,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1078915,14851,1
EAPR,PHL,Philippines,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1092700,16698,2
EAPR,PHL,Philippines,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,1103957,59210,5
EAPR,PLW,Palau,2010,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,219,49,22
EAPR,PLW,Palau,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,269,92,34
EAPR,PLW,Palau,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,324,131,40
EAPR,PLW,Palau,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,270,90,33
EAPR,PLW,Palau,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,273,95,35
EAPR,PLW,Palau,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,367,200,54
EAPR,PLW,Palau,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,332,184,55
EAPR,PLW,Palau,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,294,184,63
EAPR,PLW,Palau,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,217,178,82
EAPR,PLW,Palau,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,234,198,85
EAPR,PLW,Palau,2010,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,219,19,9
EAPR,PLW,Palau,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,269,12,4
EAPR,PLW,Palau,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,324,36,11
EAPR,PLW,Palau,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,270,61,23
EAPR,PLW,Palau,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,273,70,26
EAPR,PLW,Palau,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,367,87,24
EAPR,PLW,Palau,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,332,102,31
EAPR,PLW,Palau,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,294,105,36
EAPR,PLW,Palau,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,217,103,47
EAPR,PLW,Palau,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,234,157,67
EAPR,PLW,Palau,2010,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,168,2,1
EAPR,PLW,Palau,2011,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,110,5,5
EAPR,PLW,Palau,2012,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,63,9,14
EAPR,PLW,Palau,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,59,18,31
EAPR,PLW,Palau,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,75,42,56
EAPR,PLW,Palau,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,99,71,72
EAPR,PLW,Palau,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,144,113,78
EAPR,PLW,Palau,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,170,150,88
EAPR,PLW,Palau,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,180,158,88
EAPR,PLW,Palau,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,88
EAPR,PLW,Palau,2010,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,168,1,1
EAPR,PLW,Palau,2011,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,110,4,4
EAPR,PLW,Palau,2012,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,63,7,11
EAPR,PLW,Palau,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,59,13,22
EAPR,PLW,Palau,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,75,24,32
EAPR,PLW,Palau,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,99,30,30
EAPR,PLW,Palau,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,144,57,40
EAPR,PLW,Palau,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,170,127,75
EAPR,PLW,Palau,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,180,142,79
EAPR,PLW,Palau,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,79
Industrialized,PRT,Portugal,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,93
Industrialized,PRT,Portugal,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,93
Industrialized,PRT,Portugal,2010,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,88
Industrialized,PRT,Portugal,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,85
Industrialized,PRT,Portugal,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,87
Industrialized,PRT,Portugal,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,88
Industrialized,PRT,Portugal,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,87
Industrialized,PRT,Portugal,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,88
Industrialized,PRT,Portugal,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,85
Industrialized,PRT,Portugal,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,83
Industrialized,PRT,Portugal,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,80
Industrialized,PRT,Portugal,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,81
Industrialized,PRT,Portugal,2010,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,91
Industrialized,PRT,Portugal,2011,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,92
Industrialized,PRT,Portugal,2012,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,93
Industrialized,PRT,Portugal,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,94
Industrialized,PRT,Portugal,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,94
Industrialized,PRT,Portugal,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,94
Industrialized,PRT,Portugal,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,93
Industrialized,PRT,Portugal,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,91
Industrialized,PRT,Portugal,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,91
Industrialized,PRT,Portugal,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,91
Industrialized,PRT,Portugal,2010,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,90
Industrialized,PRT,Portugal,2011,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,91
Industrialized,PRT,Portugal,2012,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,91
Industrialized,PRT,Portugal,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,92
Industrialized,PRT,Portugal,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,54560,49873,91
Industrialized,PRT,Portugal,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,89
Industrialized,PRT,Portugal,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,91
Industrialized,PRT,Portugal,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,86
Industrialized,PRT,Portugal,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,88
Industrialized,PRT,Portugal,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,95
LACR,PRY,Paraguay,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,130425,107410,82
LACR,PRY,Paraguay,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,64864,46586,72
LACR,PRY,Paraguay,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,65442,36763,56
LACR,PRY,Paraguay,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,65880,49714,75
LACR,PRY,Paraguay,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,66284,44437,67
LACR,PRY,Paraguay,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,66634,45009,68
LACR,PRY,Paraguay,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,66723,46847,70
LACR,PRY,Paraguay,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,66520,36260,55
LACR,PRY,Paraguay,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,130425,92725,71
LACR,PRY,Paraguay,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,64864,19325,30
LACR,PRY,Paraguay,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,65442,24957,38
LACR,PRY,Paraguay,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,65880,40687,62
LACR,PRY,Paraguay,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,66284,42231,64
LACR,PRY,Paraguay,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,66634,36326,55
LACR,PRY,Paraguay,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,66723,40584,61
LACR,PRY,Paraguay,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,66520,20733,31
LACR,PRY,Paraguay,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,64822,56768,88
LACR,PRY,Paraguay,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,64188,52400,82
LACR,PRY,Paraguay,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,64280,45981,72
LACR,PRY,Paraguay,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,64830,44810,69
LACR,PRY,Paraguay,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,64822,49775,77
LACR,PRY,Paraguay,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,64188,47242,74
LACR,PRY,Paraguay,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,64280,43094,67
LACR,PRY,Paraguay,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,64830,42125,65
ESAR,RWA,Rwanda,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,124579,45381,36
ESAR,RWA,Rwanda,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,48
ESAR,RWA,Rwanda,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,60
ESAR,RWA,Rwanda,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,72
ESAR,RWA,Rwanda,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,136568,114433,84
ESAR,RWA,Rwanda,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,140469,124820,89
ESAR,RWA,Rwanda,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,144586,127868,88
ESAR,RWA,Rwanda,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,148587,135652,91
ESAR,RWA,Rwanda,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,152864,148675,97
ESAR,RWA,Rwanda,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,156623,138930,89
ESAR,RWA,Rwanda,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,124579,43163,35
ESAR,RWA,Rwanda,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,45
ESAR,RWA,Rwanda,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,56
ESAR,RWA,Rwanda,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,67
ESAR,RWA,Rwanda,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,136568,106027,78
ESAR,RWA,Rwanda,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,140469,120953,86
ESAR,RWA,Rwanda,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,144586,120594,83
ESAR,RWA,Rwanda,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,148587,128961,87
ESAR,RWA,Rwanda,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,152864,144217,94
ESAR,RWA,Rwanda,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,156623,106120,68
ESAR,RWA,Rwanda,2012,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,118594,21186,18
ESAR,RWA,Rwanda,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,121299,36150,30
ESAR,RWA,Rwanda,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,124116,49792,40
ESAR,RWA,Rwanda,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,126965,34072,27
ESAR,RWA,Rwanda,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,129916,13687,11
ESAR,RWA,Rwanda,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,132792,145894,99
ESAR,RWA,Rwanda,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,136022,115058,85
ESAR,RWA,Rwanda,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,139870,124929,89
ESAR,RWA,Rwanda,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,144111,127868,89
ESAR,RWA,Rwanda,2012,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,118594,20791,18
ESAR,RWA,Rwanda,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,121299,35097,29
ESAR,RWA,Rwanda,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,124116,46661,38
ESAR,RWA,Rwanda,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,126965,31767,25
ESAR,RWA,Rwanda,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,129916,12675,10
ESAR,RWA,Rwanda,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,132792,145484,99
ESAR,RWA,Rwanda,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,136022,106531,78
ESAR,RWA,Rwanda,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,139870,121032,87
ESAR,RWA,Rwanda,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,144111,120594,84
WCAR,SEN,Senegal,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,221101,191148,86
WCAR,SEN,Senegal,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,227185,103143,45
WCAR,SEN,Senegal,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,221101,54674,25
WCAR,SEN,Senegal,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,227185,70689,31
EAPR,SGP,Singapore,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,156319,262,0
EAPR,SGP,Singapore,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,154262,296,0
EAPR,SGP,Singapore,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,150053,426,0
EAPR,SGP,Singapore,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,145054,281,0
EAPR,SGP,Singapore,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,0
EAPR,SGP,Singapore,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,141701,393,0
EAPR,SGP,Singapore,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,141468,535,0
EAPR,SGP,Singapore,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,0
EAPR,SGP,Singapore,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,156319,163,0
EAPR,SGP,Singapore,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,154348,239,0
EAPR,SGP,Singapore,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,150180,292,0
EAPR,SGP,Singapore,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,145270,212,0
EAPR,SGP,Singapore,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,0
EAPR,SGP,Singapore,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,141842,148,0
EAPR,SGP,Singapore,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,141766,109,0
EAPR,SGP,Singapore,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,0
EAPR,SGP,Singapore,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,30751,72,0
EAPR,SGP,Singapore,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,30798,159,1
EAPR,SGP,Singapore,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,29880,260,1
EAPR,SGP,Singapore,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,27996,258,1
EAPR,SGP,Singapore,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,25812,224,1
EAPR,SGP,Singapore,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,24225,219,1
EAPR,SGP,Singapore,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,23733,276,1
EAPR,SGP,Singapore,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,30751,59,0
EAPR,SGP,Singapore,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,30798,143,1
EAPR,SGP,Singapore,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,29880,215,1
EAPR,SGP,Singapore,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,27996,188,1
EAPR,SGP,Singapore,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,25812,150,1
EAPR,SGP,Singapore,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,24225,131,1
EAPR,SGP,Singapore,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,23733,118,1
EAPR,SLB,Solomon Islands,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,38162,25743,67
EAPR,SLB,Solomon Islands,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,39327,8709,22
EAPR,SLB,Solomon Islands,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,67
LACR,SLV,El Salvador,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,55871,15286,27
Industrialized,SMR,San Marino,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,179,32,18
Industrialized,SMR,San Marino,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,178,26,15
Industrialized,SMR,San Marino,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,169,29,17
Industrialized,SMR,San Marino,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,181,17,9
Industrialized,SMR,San Marino,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,165,29,18
Industrialized,SMR,San Marino,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,160,60,38
Industrialized,SMR,San Marino,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,158,88,56
Industrialized,SMR,San Marino,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,170,82,48
Industrialized,SMR,San Marino,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,175,67,38
Industrialized,SMR,San Marino,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,179,36,20
Industrialized,SMR,San Marino,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,178,27,15
Industrialized,SMR,San Marino,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,169,28,17
Industrialized,SMR,San Marino,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,181,27,15
Industrialized,SMR,San Marino,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,165,19,12
Industrialized,SMR,San Marino,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,165,23,14
Industrialized,SMR,San Marino,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,158,64,41
Industrialized,SMR,San Marino,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,170,85,50
Industrialized,SMR,San Marino,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,175,88,50
Industrialized,SMR,San Marino,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,179,2,1
Industrialized,SMR,San Marino,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,186,1,1
Industrialized,SMR,San Marino,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,191,8,4
Industrialized,SMR,San Marino,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,183,28,15
Industrialized,SMR,San Marino,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,183,21,11
Industrialized,SMR,San Marino,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,173,46,27
Industrialized,SMR,San Marino,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,185,67,36
Industrialized,SMR,San Marino,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,169,42,25
Industrialized,SMR,San Marino,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,179,1,1
Industrialized,SMR,San Marino,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,186,11,6
Industrialized,SMR,San Marino,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,191,26,14
Industrialized,SMR,San Marino,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,183,24,13
Industrialized,SMR,San Marino,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,183,12,7
Industrialized,SMR,San Marino,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,173,50,29
Industrialized,SMR,San Marino,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,185,60,32
Industrialized,SMR,San Marino,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,169,34,20
LACR,SUR,Suriname,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,24792,15593,63
LACR,SUR,Suriname,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,4973,3360,68
LACR,SUR,Suriname,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,4975,1836,37
LACR,SUR,Suriname,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,68
LACR,SUR,Suriname,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,9975,6751,68
LACR,SUR,Suriname,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,5023,2580,51
LACR,SUR,Suriname,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,5047,861,17
LACR,SUR,Suriname,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,24792,9853,40
LACR,SUR,Suriname,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,4973,3360,68
LACR,SUR,Suriname,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,4975,1836,37
LACR,SUR,Suriname,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,55
LACR,SUR,Suriname,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,9975,5518,55
LACR,SUR,Suriname,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,5023,1897,38
LACR,SUR,Suriname,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,5047,207,4
LACR,SUR,Suriname,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,63
LACR,SUR,Suriname,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,63
LACR,SUR,Suriname,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,63
LACR,SUR,Suriname,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,63
LACR,SUR,Suriname,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,63
LACR,SUR,Suriname,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,40
LACR,SUR,Suriname,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,40
LACR,SUR,Suriname,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,40
LACR,SUR,Suriname,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,40
LACR,SUR,Suriname,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,40
Industrialized,SVN,Slovenia,2010,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,49
Industrialized,SVN,Slovenia,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,55
Industrialized,SVN,Slovenia,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,55
Industrialized,SVN,Slovenia,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,49
Industrialized,SVN,Slovenia,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,46
Industrialized,SVN,Slovenia,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,45
Industrialized,SVN,Slovenia,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,44
Industrialized,SVN,Slovenia,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,46
Industrialized,SVN,Slovenia,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,50
Industrialized,SVN,Slovenia,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,59
Industrialized,SVN,Slovenia,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,59
Industrialized,SVN,Slovenia,2010,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,49
Industrialized,SVN,Slovenia,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,55
Industrialized,SVN,Slovenia,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,55
Industrialized,SVN,Slovenia,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,49
Industrialized,SVN,Slovenia,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,46
Industrialized,SVN,Slovenia,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,45
Industrialized,SVN,Slovenia,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,44
Industrialized,SVN,Slovenia,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,46
Industrialized,SVN,Slovenia,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,50
Industrialized,SVN,Slovenia,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,59
Industrialized,SVN,Slovenia,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,10392,6062,59
Industrialized,SVN,Slovenia,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,8887,3942,44
Industrialized,SVN,Slovenia,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,8771,4141,47
Industrialized,SVN,Slovenia,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,8711,4498,52
Industrialized,SVN,Slovenia,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,8650,3424,40
Industrialized,SVN,Slovenia,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,8710,3840,44
Industrialized,SVN,Slovenia,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,8945,3622,40
Industrialized,SVN,Slovenia,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,9287,3753,40
Industrialized,SVN,Slovenia,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,8887,3942,44
Industrialized,SVN,Slovenia,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,8771,4141,47
Industrialized,SVN,Slovenia,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,8711,4498,52
Industrialized,SVN,Slovenia,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,8650,3424,40
Industrialized,SVN,Slovenia,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,8710,3840,44
Industrialized,SVN,Slovenia,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,8945,3622,40
Industrialized,SVN,Slovenia,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,9287,3753,40
Industrialized,SWE,Sweden,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,81
Industrialized,SWE,Sweden,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,80
Industrialized,SWE,Sweden,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,78
Industrialized,SWE,Sweden,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,82
Industrialized,SWE,Sweden,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,86
Industrialized,SWE,Sweden,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,89
Industrialized,SWE,Sweden,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,73
Industrialized,SWE,Sweden,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,72
Industrialized,SWE,Sweden,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,75
Industrialized,SWE,Sweden,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,80
Industrialized,SWE,Sweden,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,82
Industrialized,SWE,Sweden,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,82
Industrialized,SWE,Sweden,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,83
Industrialized,SWE,Sweden,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,82
Industrialized,SWE,Sweden,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,82
Industrialized,SWE,Sweden,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,81
Industrialized,SWE,Sweden,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,86
Industrialized,SWE,Sweden,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,76
Industrialized,SWE,Sweden,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,75
Industrialized,SWE,Sweden,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,80
ESAR,SYC,Seychelles,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,636,534,84
ESAR,SYC,Seychelles,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,650,618,95
ESAR,SYC,Seychelles,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,670,668,100
ESAR,SYC,Seychelles,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,691,616,89
ESAR,SYC,Seychelles,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,712,680,96
ESAR,SYC,Seychelles,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,732,705,96
ESAR,SYC,Seychelles,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,636,528,83
ESAR,SYC,Seychelles,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,650,605,93
ESAR,SYC,Seychelles,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,670,663,99
ESAR,SYC,Seychelles,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,691,566,82
ESAR,SYC,Seychelles,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,712,685,96
ESAR,SYC,Seychelles,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,732,498,68
ESAR,SYC,Seychelles,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,745,182,24
ESAR,SYC,Seychelles,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,627,535,85
ESAR,SYC,Seychelles,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,642,614,96
ESAR,SYC,Seychelles,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,663,669,99
ESAR,SYC,Seychelles,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,627,533,85
ESAR,SYC,Seychelles,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,642,595,93
ESAR,SYC,Seychelles,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,663,654,99
EAPR,THA,Thailand,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,409382,329231,80
EAPR,THA,Thailand,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,404643,266527,66
EAPR,THA,Thailand,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,138072,104805,76
EAPR,THA,Thailand,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,404599,266527,66
CEECIS,TKM,Turkmenistan,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,101092,98042,97
CEECIS,TKM,Turkmenistan,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,103143,98476,95
CEECIS,TKM,Turkmenistan,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,107953,112028,99
CEECIS,TKM,Turkmenistan,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,115752,122572,99
CEECIS,TKM,Turkmenistan,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,99
CEECIS,TKM,Turkmenistan,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,103143,98193,95
CEECIS,TKM,Turkmenistan,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,107953,111711,99
CEECIS,TKM,Turkmenistan,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,115752,122258,99
CEECIS,TKM,Turkmenistan,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,99
LACR,TTO,Trinidad and Tobago,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,8769,1699,19
LACR,TTO,Trinidad and Tobago,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,18312,2508,14
LACR,TTO,Trinidad and Tobago,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,18586,9841,53
LACR,TTO,Trinidad and Tobago,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,18867,3991,21
LACR,TTO,Trinidad and Tobago,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,19156,5999,31
LACR,TTO,Trinidad and Tobago,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,19390,3469,18
LACR,TTO,Trinidad and Tobago,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,8769,687,8
LACR,TTO,Trinidad and Tobago,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,18312,1179,6
LACR,TTO,Trinidad and Tobago,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,18586,1126,6
LACR,TTO,Trinidad and Tobago,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,18867,2355,12
LACR,TTO,Trinidad and Tobago,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,19156,2685,14
LACR,TTO,Trinidad and Tobago,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,19390,1686,9
LACR,TTO,Trinidad and Tobago,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,18226,2508,14
LACR,TTO,Trinidad and Tobago,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,18226,1179,6
ESAR,TZA,United Republic of Tanzania,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,665543,339643,51
ESAR,TZA,United Republic of Tanzania,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,688398,534231,78
ESAR,TZA,United Republic of Tanzania,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,711890,585292,82
ESAR,TZA,United Republic of Tanzania,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,665543,128021,19
ESAR,TZA,United Republic of Tanzania,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,688398,334649,49
ESAR,TZA,United Republic of Tanzania,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,711890,412415,58
ESAR,TZA,United Republic of Tanzania,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,664340,321692,48
ESAR,TZA,United Republic of Tanzania,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,687321,531805,77
ESAR,TZA,United Republic of Tanzania,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,664340,112160,17
ESAR,TZA,United Republic of Tanzania,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,687321,317243,46
ESAR,UGA,Uganda,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,571579,709558,99
ESAR,UGA,Uganda,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,591921,725350,99
ESAR,UGA,Uganda,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,612430,755428,99
ESAR,UGA,Uganda,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,632022,693789,99
ESAR,UGA,Uganda,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,650039,483067,74
ESAR,UGA,Uganda,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,571579,174283,30
ESAR,UGA,Uganda,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,591921,338237,57
ESAR,UGA,Uganda,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,612430,451959,74
ESAR,UGA,Uganda,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,632022,401797,64
ESAR,UGA,Uganda,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,650039,192723,30
LACR,URY,Uruguay,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,24240,8348,34
LACR,URY,Uruguay,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,23898,14446,60
LACR,URY,Uruguay,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,68
LACR,URY,Uruguay,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,23206,17512,75
LACR,URY,Uruguay,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,22856,17632,77
LACR,URY,Uruguay,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,22602,8676,38
LACR,URY,Uruguay,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,24240,6324,26
LACR,URY,Uruguay,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,23898,10758,45
LACR,URY,Uruguay,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,44
LACR,URY,Uruguay,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,23206,10065,43
LACR,URY,Uruguay,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,22856,8619,38
LACR,URY,Uruguay,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,22602,5610,25
LACR,URY,Uruguay,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,24168,9529,39
LACR,URY,Uruguay,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,23843,14784,62
LACR,URY,Uruguay,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,23473,15628,67
LACR,URY,Uruguay,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,24168,7830,32
LACR,URY,Uruguay,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,23843,11545,48
LACR,URY,Uruguay,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,23473,11541,49
Industrialized,USA,United States,2010,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,39
Industrialized,USA,United States,2011,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,42
Industrialized,USA,United States,2012,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,47
Industrialized,USA,United States,2013,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,51
Industrialized,USA,United States,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,51
Industrialized,USA,United States,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,56
Industrialized,USA,United States,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,55
Industrialized,USA,United States,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,65
Industrialized,USA,United States,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,61
Industrialized,USA,United States,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,68
Industrialized,USA,United States,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,68
Industrialized,USA,United States,2010,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,23
Industrialized,USA,United States,2011,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,23
Industrialized,USA,United States,2012,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,20
Industrialized,USA,United States,2013,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,26
Industrialized,USA,United States,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,26
Industrialized,USA,United States,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,30
Industrialized,USA,United States,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,36
Industrialized,USA,United States,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,44
Industrialized,USA,United States,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,39
Industrialized,USA,United States,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,49
Industrialized,USA,United States,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,49
Industrialized,USA,United States,2010,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,51
Industrialized,USA,United States,2011,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,56
Industrialized,USA,United States,2012,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,54
Industrialized,USA,United States,2013,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,59
Industrialized,USA,United States,2014,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,61
Industrialized,USA,United States,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,63
Industrialized,USA,United States,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,68
Industrialized,USA,United States,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,67
Industrialized,USA,United States,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,71
Industrialized,USA,United States,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,76
Industrialized,USA,United States,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,,,76
Industrialized,USA,United States,2010,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,32
Industrialized,USA,United States,2011,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,38
Industrialized,USA,United States,2012,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,35
Industrialized,USA,United States,2013,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,39
Industrialized,USA,United States,2014,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,41
Industrialized,USA,United States,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,44
Industrialized,USA,United States,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,52
Industrialized,USA,United States,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,53
Industrialized,USA,United States,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,55
Industrialized,USA,United States,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,62
Industrialized,USA,United States,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,62
CEECIS,UZB,Uzbekistan,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,301684,291766,97
CEECIS,UZB,Uzbekistan,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,307819,370914,99
CEECIS,UZB,Uzbekistan,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,300945,300893,100
LACR,VCT,Saint Vincent and the Grenadines,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,833,123,15
LACR,VCT,Saint Vincent and the Grenadines,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,822,32,4
LACR,VCT,Saint Vincent and the Grenadines,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,819,86,11
LACR,VCT,Saint Vincent and the Grenadines,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,825,26,3
LACR,VCT,Saint Vincent and the Grenadines,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,822,32,4
LACR,VCT,Saint Vincent and the Grenadines,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,819,85,10
LACR,VCT,Saint Vincent and the Grenadines,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,825,103,12
ESAR,ZAF,South Africa,2014,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,503507,419520,83
ESAR,ZAF,South Africa,2015,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,518909,427400,82
ESAR,ZAF,South Africa,2016,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,533212,418970,79
ESAR,ZAF,South Africa,2017,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,546681,378781,69
ESAR,ZAF,South Africa,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,69
ESAR,ZAF,South Africa,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,,,69
ESAR,ZAF,South Africa,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,568075,19091,3
ESAR,ZAF,South Africa,2014,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,503507,329626,65
ESAR,ZAF,South Africa,2015,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,518909,318422,61
ESAR,ZAF,South Africa,2016,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,533212,326211,61
ESAR,ZAF,South Africa,2017,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,546681,306028,56
ESAR,ZAF,South Africa,2018,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,557058,237739,43
ESAR,ZAF,South Africa,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,,,43
ESAR,ZAF,South Africa,2015,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,475982,1591,0
ESAR,ZAF,South Africa,2016,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,476935,5807,1
ESAR,ZAF,South Africa,2017,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,477206,15516,3
ESAR,ZAF,South Africa,2018,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,481504,46865,10
ESAR,ZAF,South Africa,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,492006,145420,30
ESAR,ZAF,South Africa,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,506449,377673,75
ESAR,ZAF,South Africa,2015,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,475982,1365,0
ESAR,ZAF,South Africa,2016,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,476935,4869,1
ESAR,ZAF,South Africa,2017,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,477206,13775,3
ESAR,ZAF,South Africa,2018,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,481504,42969,9
ESAR,ZAF,South Africa,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,492006,136989,28
ESAR,ZAF,South Africa,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,506449,309518,61
ESAR,ZMB,Zambia,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,224580,252051,99
ESAR,ZMB,Zambia,2020,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,229935,171432,75
ESAR,ZMB,Zambia,2020,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,224377,153986,69
ESAR,ZMB,Zambia,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,224377,257355,99
ESAR,ZMB,Zambia,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,224377,153986,69
ESAR,ZWE,Zimbabwe,2018,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,902758,751367,83
ESAR,ZWE,Zimbabwe,2019,HPV,PRHPV1_F,Target population who received the first dose of HPV vaccine in the reporting year,197881,180703,91
ESAR,ZWE,Zimbabwe,2019,HPV,PRHPVC_F,Target population who received the last dose of HPV vaccine in the reporting year,929359,621184,67
ESAR,ZWE,Zimbabwe,2019,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,169658,137325,81
ESAR,ZWE,Zimbabwe,2020,HPV,15HPV1_F,Population turning 15 in the reporting year that received any time between age 9- 14 at least one dose of HPV vaccine,174857,161994,93
ESAR,ZWE,Zimbabwe,2019,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,67
ESAR,ZWE,Zimbabwe,2020,HPV,15HPVC_F,Population turning 15 in the reporting year that received any time between age 9- 14 the full recommended schedule of HPV vaccine,,,67
